UNITED STATES
SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 10-Q

(Mark One)


☒						QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the quarterly period ended ~~April~~July 1, 2023


☐						TRANSITION REPORT PURSUANT TO SECTION 13 or 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the transition period from ______ to ______

Commission File Number 001-14423

PLEXUS CORP.

(Exact name of registrant as specified in charter)


Wisconsin						39-1344447
(State or other jurisdiction of incorporation)						(I.R.S. Employer Identification No.)

One Plexus Way

Neenah, Wisconsin 54957

(Address of principal executive offices) (Zip Code)

Telephone Number (920) 969-6000

(Registrant’s telephone number, including Area Code)

Securities registered pursuant to Section 12(b) of the Act:


Title of each class	Trading Symbol	Name of each exchange on which registered
Common Stock, $0.01 par value	PLXS	The Nasdaq Global Select Market

Indicate by check mark whether the registrant: (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports); and (2) has been subject to such filing requirements for the past 90 days. Yes x No o

Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files). Yes x No o

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and "emerging growth company" in Rule 12b-2 of the Exchange Act.

Large accelerated filer

Accelerated filer

☐

Non-accelerated filer

☐

Smaller reporting company

☐

Emerging growth company

☐

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ¨

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes ☐ No ☒

As of ~~April 21,~~August 1, 2023, there were ~~27,646,537~~27,481,145 shares of common stock outstanding.

Table of Contents

PLEXUS CORP.

TABLE OF CONTENTS

~~April~~July 1, 2023



PART I. FINANCIAL INFORMATION			3
ITEM 1. FINANCIAL STATEMENTS			3
Condensed Consolidated Statements of Comprehensive Income			3
Condensed Consolidated Balance Sheet			4
Condensed Consolidated Statements of Shareholders' Equity			5
Condensed Consolidated Statements of Cash Flows			6
Notes to Condensed Consolidated Financial Statements			7
ITEM 2. MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS			1920
"Safe Harbor" Cautionary Statement Under the Private Securities Litigation Reform Act of 1995			1920
Overview			2021
Results of Operations			2123
Liquidity of Capital Resources			2628
Disclosure About Critical Accounting Policies			3032
New Accounting Pronouncements			3032
ITEM 3. QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK			3032
ITEM 4. CONTROLS AND PROCEDURES			3133
PART II. OTHER INFORMATION			3133
ITEM 1A. Risk Factors			3133
ITEM 2. Unregistered Sales of Equity Securities and Use of Proceed			3133
ITEM 5. Other Information			33
ITEM 6. Exhibits			3234
SIGNATURES			3335

Table of Contents

PART I. FINANCIAL INFORMATION

ITEM 1. FINANCIAL STATEMENTS

PLEXUS CORP. AND SUBSIDIARIES

CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME

(in thousands, except per share data)

Unaudited


		Three Months Ended				Six Months Ended					Three Months Ended				Nine Months Ended
		April 1, 2023		April 2, 2022		April 1, 2023		April 2, 2022			July 1, 2023		July 2, 2022		July 1, 2023		July 2, 2022
Net sales	Net sales	$	1,070,823	$	888,723	$	2,164,748	$	1,706,179	Net sales	$	1,021,610	$	981,341	$	3,186,358	$	2,687,520
Cost of sales	Cost of sales	967,830		812,213		1,960,556		1,559,673		Cost of sales	927,964		887,723		2,888,520		2,447,396
Gross profit	Gross profit	102,993		76,510		204,192		146,506		Gross profit	93,646		93,618		297,838		240,124
Selling and administrative expenses	Selling and administrative expenses	46,051		40,673		89,909		78,175		Selling and administrative expenses	42,348		44,057		132,257		122,232
Restructuring and impairment charges		—		—		—		2,021
Restructuring and other charges										Restructuring and other charges	23,094		—		23,094		2,021
Operating income	Operating income	56,942		35,837		114,283		66,310		Operating income	28,204		49,561		142,487		115,871
Other income (expense):	Other income (expense):									Other income (expense):
Interest expense	Interest expense	(8,287)		(3,345)		(15,181)		(6,391)		Interest expense	(8,231)		(3,923)		(23,412)		(10,314)
Interest income	Interest income	759		262		1,693		533		Interest income	598		318		2,291		851
Miscellaneous, net	Miscellaneous, net	(1,612)		(1,446)		(3,556)		(2,369)		Miscellaneous, net	(3,194)		(2,678)		(6,750)		(5,047)
Income before income taxes	Income before income taxes	47,802		31,308		97,239		58,083		Income before income taxes	17,377		43,278		114,616		101,361
Income tax expense	Income tax expense	6,958		4,439		14,205		7,791		Income tax expense	1,578		5,784		15,783		13,575
Net income	Net income	$	40,844	$	26,869	$	83,034	$	50,292	Net income	$	15,799	$	37,494	$	98,833	$	87,786
Earnings per share:	Earnings per share:									Earnings per share:
Basic	Basic	$	1.48	$	0.96	$	3.00	$	1.80	Basic	$	0.57	$	1.35	$	3.58	$	3.14
Diluted	Diluted	$	1.45	$	0.95	$	2.94	$	1.76	Diluted	$	0.56	$	1.33	$	3.51	$	3.09
Weighted average shares outstanding:	Weighted average shares outstanding:									Weighted average shares outstanding:
Basic	Basic	27,661		27,987		27,650		28,002		Basic	27,561		27,738		27,619		27,913
Diluted	Diluted	28,184		28,427		28,273		28,566		Diluted	27,992		28,179		28,169		28,452
Comprehensive income:	Comprehensive income:									Comprehensive income:
Net income	Net income	$	40,844	$	26,869	$	83,034	$	50,292	Net income	$	15,799	$	37,494	$	98,833	$	87,786
Other comprehensive income (loss):
Other comprehensive (loss) income:										Other comprehensive (loss) income:
Derivative instrument and other fair value adjustments	Derivative instrument and other fair value adjustments	2,924		436		11,363		1,708		Derivative instrument and other fair value adjustments	(6,630)		(3,239)		4,733		(1,531)
Foreign currency translation adjustments	Foreign currency translation adjustments	3,152		(4,328)		16,929		(5,906)		Foreign currency translation adjustments	2,357		(10,873)		19,286		(16,779)
Other comprehensive income (loss)		6,076		(3,892)		28,292		(4,198)
Other comprehensive (loss) income										Other comprehensive (loss) income	(4,273)		(14,112)		24,019		(18,310)
Total comprehensive income	Total comprehensive income	$	46,920	$	22,977	$	111,326	$	46,094	Total comprehensive income	$	11,526	$	23,382	$	122,852	$	69,476

The accompanying notes are an integral part of these condensed consolidated financial statements.

Table of Contents

PLEXUS CORP. AND SUBSIDIARIES

CONDENSED CONSOLIDATED BALANCE SHEETS

(in thousands, except per share data)

Unaudited


		April 1, 2023		October 1, 2022			July 1, 2023		October 1, 2022
ASSETS	ASSETS					ASSETS
Current assets:	Current assets:					Current assets:
Cash and cash equivalents	Cash and cash equivalents	$	269,664	$	274,805	Cash and cash equivalents	$	252,965	$	274,805
Restricted cash	Restricted cash	700		665		Restricted cash	589		665
Accounts receivable, net of allowances of $2,284 and $1,961, respectively		661,445		737,696
Accounts receivable, net of allowances of $3,010 and $1,961, respectively						Accounts receivable, net of allowances of $3,010 and $1,961, respectively	706,898		737,696
Contract assets	Contract assets	133,029		138,540		Contract assets	132,995		138,540
Inventories, net	Inventories, net	1,649,719		1,602,783		Inventories, net	1,641,673		1,602,783
Prepaid expenses and other	Prepaid expenses and other	65,717		61,633		Prepaid expenses and other	64,166		61,633
Total current assets	Total current assets	2,780,274		2,816,122		Total current assets	2,799,286		2,816,122
Property, plant and equipment, net	Property, plant and equipment, net	469,387		444,705		Property, plant and equipment, net	476,482		444,705
Operating lease right-of-use assets	Operating lease right-of-use assets	62,795		65,134		Operating lease right-of-use assets	71,914		65,134
Deferred income taxes	Deferred income taxes	39,405		39,075		Deferred income taxes	40,350		39,075
Other assets	Other assets	30,159		28,189		Other assets	30,911		28,189
Total non-current assets	Total non-current assets	601,746		577,103		Total non-current assets	619,657		577,103
Total assets	Total assets	$	3,382,020	$	3,393,225	Total assets	$	3,418,943	$	3,393,225

LIABILITIES AND SHAREHOLDERS’ EQUITY	LIABILITIES AND SHAREHOLDERS’ EQUITY					LIABILITIES AND SHAREHOLDERS’ EQUITY
Current liabilities:	Current liabilities:					Current liabilities:
Current portion of long-term debt and finance lease obligations	Current portion of long-term debt and finance lease obligations	$	294,011	$	273,971	Current portion of long-term debt and finance lease obligations	$	304,781	$	273,971
Accounts payable	Accounts payable	729,225		805,583		Accounts payable	697,112		805,583
Customer deposits	Customer deposits	531,683		480,486		Customer deposits	582,172		480,486
Accrued salaries and wages	Accrued salaries and wages	76,702		88,876		Accrued salaries and wages	79,935		88,876
Other accrued liabilities	Other accrued liabilities	286,241		357,273		Other accrued liabilities	276,977		357,273
Total current liabilities	Total current liabilities	1,917,862		2,006,189		Total current liabilities	1,940,977		2,006,189
Long-term debt and finance lease obligations, net of current portion	Long-term debt and finance lease obligations, net of current portion	188,730		187,776		Long-term debt and finance lease obligations, net of current portion	187,468		187,776
Accrued income taxes payable	Accrued income taxes payable	31,382		42,019		Accrued income taxes payable	31,382		42,019
Long-term operating lease liabilities	Long-term operating lease liabilities	31,257		33,628		Long-term operating lease liabilities	40,515		33,628
Deferred income taxes	Deferred income taxes	4,901		6,327		Deferred income taxes	4,444		6,327
Other liabilities	Other liabilities	25,506		21,555		Other liabilities	29,795		21,555
Total non-current liabilities	Total non-current liabilities	281,776		291,305		Total non-current liabilities	293,604		291,305
Total liabilities	Total liabilities	2,199,638		2,297,494		Total liabilities	2,234,581		2,297,494
Commitments and contingencies	Commitments and contingencies					Commitments and contingencies
Shareholders’ equity:	Shareholders’ equity:					Shareholders’ equity:
Preferred stock, $0.01 par value, 5,000 shares authorized, none issued or outstanding	Preferred stock, $0.01 par value, 5,000 shares authorized, none issued or outstanding	—		—		Preferred stock, $0.01 par value, 5,000 shares authorized, none issued or outstanding	—		—
Common stock, $0.01 par value, 200,000 shares authorized, 54,293 and 54,084 shares issued, respectively, and 27,647 and 27,679 shares outstanding, respectively		543		541
Common stock, $0.01 par value, 200,000 shares authorized, 54,294 and 54,084 shares issued, respectively, and 27,498 and 27,679 shares outstanding, respectively						Common stock, $0.01 par value, 200,000 shares authorized, 54,294 and 54,084 shares issued, respectively, and 27,498 and 27,679 shares outstanding, respectively	543		541
Additional paid-in capital	Additional paid-in capital	651,667		652,467		Additional paid-in capital	655,675		652,467
Common stock held in treasury, at cost, 26,646 and 26,405 shares, respectively		(1,117,360)		(1,093,483)
Common stock held in treasury, at cost, 26,796 and 26,405 shares, respectively						Common stock held in treasury, at cost, 26,796 and 26,405 shares, respectively	(1,130,914)		(1,093,483)
Retained earnings	Retained earnings	1,655,268		1,572,234		Retained earnings	1,671,067		1,572,234
Accumulated other comprehensive loss	Accumulated other comprehensive loss	(7,736)		(36,028)		Accumulated other comprehensive loss	(12,009)		(36,028)
Total shareholders’ equity	Total shareholders’ equity	1,182,382		1,095,731		Total shareholders’ equity	1,184,362		1,095,731
Total liabilities and shareholders’ equity	Total liabilities and shareholders’ equity	$	3,382,020	$	3,393,225	Total liabilities and shareholders’ equity	$	3,418,943	$	3,393,225

The accompanying notes are an integral part of these condensed consolidated financial statements.

Table of Contents

PLEXUS CORP. AND SUBSIDIARIES

CONDENSED CONSOLIDATED STATEMENTS OF SHAREHOLDERS’ EQUITY

(in thousands)

Unaudited


		Three Months Ended				Six Months Ended					Three Months Ended				Nine Months Ended
		April 1, 2023		April 2, 2022		April 1, 2023		April 2, 2022			July 1, 2023		July 2, 2022		July 1, 2023		July 2, 2022
Common stock - shares outstanding	Common stock - shares outstanding									Common stock - shares outstanding
Beginning of period	Beginning of period	27,612		27,997		27,679		28,047		Beginning of period	27,647		27,859		27,679		28,047
Exercise of stock options and vesting of other share-based awards	Exercise of stock options and vesting of other share-based awards	160		168		209		228		Exercise of stock options and vesting of other share-based awards	1		2		210		230
Treasury shares purchased	Treasury shares purchased	(125)		(306)		(241)		(416)		Treasury shares purchased	(150)		(149)		(391)		(565)
End of period	End of period	27,647		27,859		27,647		27,859		End of period	27,498		27,712		27,498		27,712

Total stockholders' equity, beginning of period	Total stockholders' equity, beginning of period	$	1,150,259	$	1,044,095	$	1,095,731	$	1,028,232	Total stockholders' equity, beginning of period	$	1,182,382	$	1,040,591	$	1,095,731	$	1,028,232
Common stock - par value	Common stock - par value									Common stock - par value
Beginning of period	Beginning of period	541		539		541		538		Beginning of period	543		541		541		538
Exercise of stock options and vesting of other share-based awards	Exercise of stock options and vesting of other share-based awards	2		2		2		3		Exercise of stock options and vesting of other share-based awards	—		—		2		3
End of period	End of period	543		541		543		541		End of period	543		541		543		541
Additional paid-in capital	Additional paid-in capital									Additional paid-in capital
Beginning of period	Beginning of period	654,059		642,654		652,467		639,778		Beginning of period	651,667		641,175		652,467		639,778
Share-based compensation expense	Share-based compensation expense	5,799		5,908		11,482		12,178		Share-based compensation expense	4,057		6,048		15,539		18,226
Exercise of stock options and vesting of other share-based awards, including tax withholding	Exercise of stock options and vesting of other share-based awards, including tax withholding	(8,191)		(7,387)		(12,282)		(10,781)		Exercise of stock options and vesting of other share-based awards, including tax withholding	(49)		(54)		(12,331)		(10,835)
End of period	End of period	651,667		641,175		651,667		641,175		End of period	655,675		647,169		655,675		647,169
Treasury stock	Treasury stock									Treasury stock
Beginning of period	Beginning of period	(1,104,953)		(1,053,222)		(1,093,483)		(1,043,091)		Beginning of period	(1,117,360)		(1,078,226)		(1,093,483)		(1,043,091)
Treasury shares purchased	Treasury shares purchased	(12,407)		(25,004)		(23,877)		(35,135)		Treasury shares purchased	(13,554)		(11,777)		(37,431)		(46,912)
End of period	End of period	(1,117,360)		(1,078,226)		(1,117,360)		(1,078,226)		End of period	(1,130,914)		(1,090,003)		(1,130,914)		(1,090,003)
Retained earnings	Retained earnings									Retained earnings
Beginning of period	Beginning of period	1,614,424		1,457,414		1,572,234		1,433,991		Beginning of period	1,655,268		1,484,283		1,572,234		1,433,991
Net income	Net income	40,844		26,869		83,034		50,292		Net income	15,799		37,494		98,833		87,786
End of period	End of period	1,655,268		1,484,283		1,655,268		1,484,283		End of period	1,671,067		1,521,777		1,671,067		1,521,777
Accumulated other comprehensive loss	Accumulated other comprehensive loss									Accumulated other comprehensive loss
Beginning of period	Beginning of period	(13,812)		(3,290)		(36,028)		(2,984)		Beginning of period	(7,736)		(7,182)		(36,028)		(2,984)
Other comprehensive income (loss)		6,076		(3,892)		28,292		(4,198)
Other comprehensive (loss) income										Other comprehensive (loss) income	(4,273)		(14,112)		24,019		(18,310)
End of period	End of period	(7,736)		(7,182)		(7,736)		(7,182)		End of period	(12,009)		(21,294)		(12,009)		(21,294)
Total stockholders' equity, end of period	Total stockholders' equity, end of period	$	1,182,382	$	1,040,591	$	1,182,382	$	1,040,591	Total stockholders' equity, end of period	$	1,184,362	$	1,058,190	$	1,184,362	$	1,058,190

The accompanying notes are an integral part of these condensed consolidated financial statements.

Table of Contents

PLEXUS CORP. AND SUBSIDIARIES

CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS

(in thousands)

Unaudited


		Six Months Ended					Nine Months Ended
		April 1, 2023		April 2, 2022			July 1, 2023		July 2, 2022
Cash flows from operating activities	Cash flows from operating activities					Cash flows from operating activities
Net income	Net income	$	83,034	$	50,292	Net income	$	98,833	$	87,786
Adjustments to reconcile net income to net cash flows from operating activities:	Adjustments to reconcile net income to net cash flows from operating activities:					Adjustments to reconcile net income to net cash flows from operating activities:
Depreciation and amortization	Depreciation and amortization	33,434		30,936		Depreciation and amortization	51,366		46,842
Share-based compensation expense and related charges	Share-based compensation expense and related charges	11,482		12,437		Share-based compensation expense and related charges	15,539		18,254
Other, net	Other, net	460		933		Other, net	74		2,993
Changes in operating assets and liabilities, excluding impacts of currency:	Changes in operating assets and liabilities, excluding impacts of currency:					Changes in operating assets and liabilities, excluding impacts of currency:
Accounts receivable	Accounts receivable	84,392		(54,099)		Accounts receivable	38,933		(100,850)
Contract assets	Contract assets	5,988		(335)		Contract assets	6,218		(12,672)
Inventories	Inventories	(33,910)		(405,648)		Inventories	(25,356)		(601,601)
Other current and non-current assets	Other current and non-current assets	(3,007)		(10,591)		Other current and non-current assets	(2,408)		(14,681)
Accrued income taxes payable	Accrued income taxes payable	(8,064)		(6,836)		Accrued income taxes payable	(11,711)		(6,707)
Accounts payable	Accounts payable	(86,054)		138,343		Accounts payable	(115,600)		228,509
Customer deposits	Customer deposits	47,033		160,218		Customer deposits	97,245		189,068
Other current and non-current liabilities	Other current and non-current liabilities	(77,632)		79,697		Other current and non-current liabilities	(77,148)		137,211
Cash flows provided by (used in) operating activities	Cash flows provided by (used in) operating activities	57,156		(4,653)		Cash flows provided by (used in) operating activities	75,985		(25,848)
Cash flows from investing activities	Cash flows from investing activities					Cash flows from investing activities
Payments for property, plant and equipment	Payments for property, plant and equipment	(49,491)		(64,181)		Payments for property, plant and equipment	(79,794)		(85,028)
Other, net	Other, net	1,876		(77)		Other, net	2,082		(105)
Cash flows used in investing activities	Cash flows used in investing activities	(47,615)		(64,258)		Cash flows used in investing activities	(77,712)		(85,133)
Cash flows from financing activities	Cash flows from financing activities					Cash flows from financing activities
Borrowings under debt agreements	Borrowings under debt agreements	354,000		377,000		Borrowings under debt agreements	573,000		524,000
Payments on debt and finance lease obligations	Payments on debt and finance lease obligations	(336,267)		(223,282)		Payments on debt and finance lease obligations	(545,649)		(343,207)
Debt issuance costs						Debt issuance costs	—		(898)
Repurchases of common stock	Repurchases of common stock	(23,877)		(35,135)		Repurchases of common stock	(37,431)		(46,912)
Proceeds from exercise of stock options	Proceeds from exercise of stock options	—		307		Proceeds from exercise of stock options	8		307
Payments related to tax withholding for share-based compensation	Payments related to tax withholding for share-based compensation	(12,280)		(11,089)		Payments related to tax withholding for share-based compensation	(12,337)		(11,142)
Cash flows (used in) provided by financing activities	Cash flows (used in) provided by financing activities	(18,424)		107,801		Cash flows (used in) provided by financing activities	(22,409)		122,148
Effect of exchange rate changes on cash and cash equivalents	Effect of exchange rate changes on cash and cash equivalents	3,777		(527)		Effect of exchange rate changes on cash and cash equivalents	2,220		(3,850)
Net (decrease) increase in cash and cash equivalents and restricted cash	Net (decrease) increase in cash and cash equivalents and restricted cash	(5,106)		38,363		Net (decrease) increase in cash and cash equivalents and restricted cash	(21,916)		7,317
Cash and cash equivalents and restricted cash:	Cash and cash equivalents and restricted cash:					Cash and cash equivalents and restricted cash:
Beginning of period	Beginning of period	275,470		270,513		Beginning of period	275,470		270,513
End of period	End of period	$	270,364	$	308,876	End of period	$	253,554	$	277,830

The accompanying notes are an integral part of these condensed consolidated financial statements.

Table of Contents

PLEXUS CORP. AND SUBSIDIARIES

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

FOR THE THREE AND ~~SIX~~NINE MONTHS ENDED ~~APRIL~~JULY 1, 2023 AND ~~APRIL~~JULY 2, 2022

Unaudited

1.Basis of Presentation

Basis of Presentation:

The accompanying Condensed Consolidated Financial Statements included herein have been prepared by Plexus Corp. and its subsidiaries (together “Plexus” or the “Company”) without audit and pursuant to the rules and regulations of the United States (“U.S.”) Securities and Exchange Commission (“SEC”). The accompanying Condensed Consolidated Financial Statements reflect all adjustments, which include normal recurring adjustments necessary for the fair statement of the consolidated financial position of the Company as of ~~April~~July 1, 2023 and October 1, 2022, the results of operations and shareholders' equity for the three and ~~six~~nine months ended ~~April~~July 1, 2023 and ~~April~~July 2, 2022, and the cash flows for the same ~~six~~nine month periods.

The Company’s fiscal year ends on the Saturday closest to September 30. The Company uses a “4-4-5” weekly accounting system for the interim periods in each quarter. Each quarter, therefore, ends on a Saturday at the end of the 4-4-5 period. Periodically, an additional week must be added to the fiscal year to re-align with the Saturday closest to September 30. All fiscal quarters presented herein included 13 weeks.

Certain information and footnote disclosures, normally included in financial statements prepared in accordance with generally accepted accounting principles in the United States of America ("U.S. GAAP"), have been condensed or omitted pursuant to the SEC’s rules and regulations dealing with interim financial statements. However, the Company believes that the disclosures made in the Condensed Consolidated Financial Statements included herein are adequate to make the information presented not misleading. It is suggested that these Condensed Consolidated Financial Statements be read in conjunction with the Consolidated Financial Statements and notes thereto included in the Company’s 2022 Annual Report on Form 10-K.

The preparation of financial statements requires management to make estimates and assumptions that affect the amounts reported in the Condensed Consolidated Financial Statements and notes thereto. The Company has considered information available as of the date of issuance of these financial statements and ~~other than the information disclosed in Note 16, "Subsequent Event",~~ is not aware of any specific events or circumstances that would require an update to its estimates or judgments, or a revision of the carrying value of its assets or liabilities. These estimates may change as new events occur and additional information becomes available. Actual results could differ materially from these estimates.

Recently Issued Accounting Pronouncements Not Yet Adopted:

In September 2022, the FASB issued ASU 2022-04, which requires enhanced disclosures about supplier finance programs. The guidance is effective for the Company beginning in the first quarter of fiscal 2024. Early adoption is permitted. The Company is currently in the process of assessing the impacts of the ~~guidance.~~guidance and does not expect this standard to have a material impact on its Consolidated Financial Statements.

The Company does not believe that any other recently issued accounting standards will have a material impact on its Consolidated Financial Statements, or apply to its operations.

2. Inventories

Inventories as of ~~April~~July 1, 2023 and October 1, 2022 consisted of the following (in thousands):


		April 1, 2023		October 1, 2022			July 1, 2023		October 1, 2022
Raw materials	Raw materials	$	1,477,553	$	1,433,353	Raw materials	$	1,483,790	$	1,433,353
Work-in-process	Work-in-process	82,070		81,207		Work-in-process	70,483		81,207
Finished goods	Finished goods	90,096		88,223		Finished goods	87,400		88,223
Total inventories, net	Total inventories, net	$	1,649,719	$	1,602,783	Total inventories, net	$	1,641,673	$	1,602,783

Table of Contents

In certain circumstances, per contractual terms, customer deposits are received by the Company to offset inventory risks. The total amount of customer deposits related to inventory and included within current liabilities on the accompanying Condensed Consolidated Balance Sheets as of ~~April~~July 1, 2023 and October 1, 2022 were ~~$516.7~~$569.4 million and $463.2 million, respectively.

~~Table of Contents~~

3. Debt, Finance Lease and Other Financing Obligations

Debt, finance lease and other financing obligations as of ~~April~~July 1, 2023 and October 1, 2022 consisted of the following (in thousands):


		April 1, 2023		October 1, 2022			July 1, 2023		October 1, 2022
4.05% Senior Notes, due June 15, 2025	4.05% Senior Notes, due June 15, 2025	$	100,000	$	100,000	4.05% Senior Notes, due June 15, 2025	$	100,000	$	100,000
4.22% Senior Notes, due June 15, 2028	4.22% Senior Notes, due June 15, 2028	50,000		50,000		4.22% Senior Notes, due June 15, 2028	50,000		50,000
Borrowings under Credit Facility	Borrowings under Credit Facility	284,000		263,000		Borrowings under Credit Facility	297,000		263,000
Finance lease and other financing obligations	Finance lease and other financing obligations	50,093		50,269		Finance lease and other financing obligations	46,512		50,269
Unamortized deferred financing fees	Unamortized deferred financing fees	(1,352)		(1,522)		Unamortized deferred financing fees	(1,263)		(1,522)
Total obligations	Total obligations	482,741		461,747		Total obligations	492,249		461,747
Less: current portion	Less: current portion	(294,011)		(273,971)		Less: current portion	(304,781)		(273,971)
Long-term debt, finance lease and other financing obligations, net of current portion	Long-term debt, finance lease and other financing obligations, net of current portion	$	188,730	$	187,776	Long-term debt, finance lease and other financing obligations, net of current portion	$	187,468	$	187,776

As of ~~April~~July 1, 2023, the Company was in compliance with covenants for all debt agreements.

During the ~~six~~nine months ended ~~April~~July 1, 2023, the highest daily borrowing under the Company's 5-year senior unsecured revolving credit facility (referred to as the "Credit Facility") was $412.0 million; the average daily balance was ~~$344.5~~$341.9 million. During the ~~six~~nine months ended ~~April~~July 2, 2022, the highest daily borrowing was ~~$294.0~~$327.0 million; the average daily balance was ~~$168.7~~$204.9 million.

The fair value of the Company’s debt, excluding finance lease and other financing obligations, was $~~428.3~~439.0 million and $401.6 million as of ~~April~~July 1, 2023 and October 1, 2022, respectively. The carrying value of the Company's debt, excluding finance lease and other financing obligations, was $~~434.0~~447.0 million and $413.0 million as of ~~April~~July 1, 2023 and October 1, 2022, respectively. If measured at fair value in the financial statements, the Company's debt would be classified as Level 2 in the fair value hierarchy. Refer to Note 4, "Derivatives and Fair Value Measurements," for further information regarding the Company's fair value calculations and classifications.

4. Derivatives and Fair Value Measurements

All derivatives are recognized in the accompanying Condensed Consolidated Balance Sheets at their estimated fair value. The Company uses derivatives to manage the variability of foreign currency obligations. The Company has cash flow hedges related to forecasted foreign currency obligations, in addition to non-designated hedges to manage foreign currency exposures associated with certain foreign currency denominated assets and liabilities. The Company does not enter into derivatives for speculative purposes.

The Company designates some foreign currency exchange contracts as cash flow hedges of forecasted foreign currency expenses. Changes in the fair value of the derivatives that qualify as cash flow hedges are recorded in "Accumulated other comprehensive loss" in the accompanying Condensed Consolidated Balance Sheets until earnings are affected by the variability of the cash flows. In the next twelve months, the Company estimates that ~~$5.3~~$1.3 million of unrealized ~~gains,~~losses, net of tax, related to cash flow hedges will be reclassified from other comprehensive (loss) income ~~(loss)~~ into earnings. Changes in the fair value of the non-designated derivatives related to recognized foreign currency denominated assets and liabilities are recorded in "Miscellaneous, net" in the accompanying Condensed Consolidated Statements of Comprehensive Income.

The Company enters into forward currency exchange contracts for its operations in certain jurisdictions in the AMER and APAC segments on a rolling basis. The Company had cash flow hedges outstanding with a notional value of ~~$192.9~~$215.0 million as of ~~April~~July 1, 2023, and a notional value of $143.2 million as of October 1, 2022. These forward currency contracts fix the exchange rates for the settlement of future foreign currency obligations that have yet to be realized. The total fair value of the forward currency exchange contracts was a ~~$5.3~~$1.3 million ~~asset~~liability as of ~~April~~July 1, 2023, and a $6.0 million liability as of October 1, 2022.

Table of Contents

The Company had additional forward currency exchange contracts outstanding as of ~~April~~July 1, 2023, with a notional value of ~~$126.2~~$123.4 million; there were $60.1 million of such contracts outstanding as of October 1, 2022. The Company did not designate these derivative instruments as hedging instruments. The net settlement amount (fair value) related to these contracts is recorded on the Condensed Consolidated Balance Sheets as either a current or long-term asset or liability, depending on the term, and as an element of "Miscellaneous, net" in the Condensed Consolidated Statements of Comprehensive Income. The

~~Table of Contents~~

total fair value of these derivatives was a ~~$0.5~~$0.3 million liability as of ~~April~~July 1, 2023, and a $0.3 million asset as of October 1, 2022.

The tables below present information regarding the fair values of derivative instruments and the effects of derivative instruments on the Company’s Condensed Consolidated Financial Statements:

Fair Values of Derivative Instruments (in thousands)

Derivative Assets

Derivative Liabilities

Derivative Assets

Derivative Liabilities

April 1,
2023

October 1,
2022

April 1,
2023

October 1,
2022

July 1,
2023

October 1,
2022

July 1,
2023

October 1,
2022

Derivatives designated as hedging instruments

Balance sheet
classification

Fair Value

Balance sheet
classification

Fair Value

Derivatives designated as hedging instruments

Balance sheet
classification

Fair Value

Balance sheet
classification

Fair Value

Foreign currency forward contracts

Prepaid expenses and other

5,454

715

Other accrued liabilities

123

6,747

Foreign currency forward contracts

Prepaid expenses and other

5,504

715

Other accrued liabilities

6,803

6,747

Fair Values of Derivative Instruments (in thousands)

Derivative Assets

Derivative Liabilities

Derivative Assets

Derivative Liabilities

April 1,
2023

October 1,
2022

April 1,
2023

October 1,
2022

July 1,
2023

October 1,
2022

July 1,
2023

October 1,
2022

Derivatives not designated as hedging instruments

Balance sheet
classification

Fair Value

Balance sheet
classification

Fair Value

Derivatives not designated as hedging instruments

Balance sheet
classification

Fair Value

Balance sheet
classification

Fair Value

Foreign currency forward contracts

Prepaid expenses and other

907

1,555

Other accrued liabilities

1,382

1,249

Foreign currency forward contracts

Prepaid expenses and other

1,578

1,555

Other accrued liabilities

1,926

1,249

The Effect of Cash Flow Hedge Accounting on Accumulated Other Comprehensive Loss ("OCL") (in thousands)

for the Three Months Ended

Derivatives in cash flow hedging relationships

Amount of Gain Recognized in OCL on Derivatives

Derivatives in cash flow hedging relationships

Amount of Loss Recognized in OCL on Derivatives

April 1, 2023

April 2, 2022

July 1, 2023

July 2, 2022

Foreign currency forward contracts

3,574

317

Foreign currency forward contracts

(5,523)

(3,588)

Derivative Impact on Gain (Loss) Recognized in Condensed Consolidated Statements of Comprehensive Income (in thousands)

for the Three Months Ended

Derivatives in cash flow hedging relationships

Classification of Gain (Loss) Reclassified from Accumulated OCL into Income

Amount of Gain (Loss) Reclassified from Accumulated OCL into Income

Derivatives in cash flow hedging relationships

Classification of Gain (Loss) Reclassified from Accumulated OCL into Income

Amount of Gain (Loss) Reclassified from Accumulated OCL into Income

April 1, 2023

April 2, 2022

July 1, 2023

July 2, 2022

Foreign currency forward contracts

Cost of sales

516

(109)

Foreign currency forward contracts

Cost of sales

1,047

(322)

Foreign currency forward contracts

Selling and administrative expenses

134

(10)

Foreign currency forward contracts

Selling and administrative expenses

(27)

Derivatives not designated as hedging instruments

Location of Loss Recognized on Derivatives in Income

Amount of Loss on Derivatives Recognized in Income

Derivatives not designated as hedging instruments

Location of Loss Recognized on Derivatives in Income

Amount of Loss on Derivatives Recognized in Income

April 1, 2023

April 2, 2022

July 1, 2023

July 2, 2022

Foreign currency forward contracts

Miscellaneous, net

(684)

(782)

Foreign currency forward contracts

Miscellaneous, net

(574)

(790)

The Effect of Cash Flow Hedge Accounting on Accumulated Other Comprehensive Loss ("OCL") (in thousands)

for the Six Months Ended

for the Nine Months Ended

Derivatives in cash flow hedging relationships

Amount of Gain Recognized in OCL on Derivatives

Derivatives in cash flow hedging relationships

Amount of Gain (Loss) Recognized in OCL on Derivatives

April 1, 2023

April 2, 2022

July 1, 2023

July 2, 2022

Foreign currency forward contracts

9,724

787

Foreign currency forward contracts

4,201

(2,801)

Table of Contents

Derivative Impact on (Loss) Gain Recognized in Condensed Consolidated Statements of Comprehensive Income (in thousands)

for the Six Months Ended

for the Nine Months Ended

Derivatives in cash flow hedging relationships

Classification of Loss Reclassified from Accumulated OCL into Income

Amount of Loss Reclassified from Accumulated OCL into Income

Derivatives in cash flow hedging relationships

Classification of (Loss) Gain Reclassified from Accumulated OCL into Income

Amount of (Loss) Gain Reclassified from Accumulated OCL into Income

April 1, 2023

April 2, 2022

July 1, 2023

July 2, 2022

Foreign currency forward contracts

Cost of sales

(1,616)

(852)

Foreign currency forward contracts

Cost of sales

(569)

(1,174)

Foreign currency forward contracts

Selling and administrative expenses

(23)

(69)

Foreign currency forward contracts

Selling and administrative expenses

(96)

Derivatives not designated as hedging instruments

Location of Gain (Loss) Recognized on Derivatives in Income

Amount of Gain (Loss) on Derivatives Recognized in Income

Derivatives not designated as hedging instruments

Location of Loss Recognized on Derivatives in Income

Amount of Loss on Derivatives Recognized in Income

April 1, 2023

April 2, 2022

July 1, 2023

July 2, 2022

Foreign currency forward contracts

Miscellaneous, net

(825)

Foreign currency forward contracts

Miscellaneous, net

(511)

(1,615)

Fair Value Measurements:

Fair value is defined as the exchange price that would be received for an asset or paid to transfer a liability (or exit price) in the principal or most advantageous market for the asset or liability in an orderly transaction between market participants on the measurement date. Valuation techniques used to measure fair value must maximize the use of observable inputs and minimize the use of unobservable inputs. The Company uses quoted market prices when available or discounted cash flows to calculate fair value. The accounting guidance establishes a fair value hierarchy based on three levels of inputs that may be used to measure fair value. The input levels are:

Level 1: Quoted (observable) market prices in active markets for identical assets or liabilities.

Level 2: Inputs other than Level 1 that are observable, such as quoted prices for similar assets or liabilities; quoted prices in markets that are not active; or other inputs that are observable or can be corroborated by observable market data for substantially the full term of the asset or liability.

Level 3: Unobservable inputs that are supported by little or no market activity and that are significant to the fair value of the asset or liability.

The following table lists the fair values of assets of the Company’s derivatives as of ~~April~~July 1, 2023 and October 1, 2022, by input level:


Fair Value Measurements Using Input Levels Asset/(Liability) (in thousands)
Fiscal period ended April 1, 2023		Level 1		Level 2		Level 3		Total
Fair Value Measurements Using Input Levels Liability (in thousands)										Fair Value Measurements Using Input Levels Liability (in thousands)
Fiscal period ended July 1, 2023										Fiscal period ended July 1, 2023	Level 1		Level 2		Level 3		Total
Derivatives	Derivatives									Derivatives
Foreign currency forward contracts	Foreign currency forward contracts	$	—	$	4,856	$	—	$	4,856	Foreign currency forward contracts	$	—	$	1,647	$	—	$	1,647

Fiscal period ended October 1, 2022	Fiscal period ended October 1, 2022									Fiscal period ended October 1, 2022
Derivatives	Derivatives									Derivatives
Foreign currency forward contracts	Foreign currency forward contracts	$	—	$	(5,726)	$	—	$	(5,726)	Foreign currency forward contracts	$	—	$	5,726	$	—	$	5,726

The fair value of foreign currency forward contracts is determined using a market approach, which includes obtaining directly or indirectly observable values from third parties active in the relevant markets. Inputs in the fair value of the foreign currency forward contracts include prevailing forward and spot prices for currency.

5. Income Taxes

Income tax expense for the three and ~~six~~nine months ended ~~April~~July 1, 2023 was ~~$7.0~~$1.6 million and ~~$14.2~~$15.8 million, respectively, compared to ~~$4.4~~$5.8 million and ~~$7.8~~$13.6 million for the three and ~~six~~nine months ended ~~April~~July 2, 2022, respectively.

The effective tax ~~rate~~rates for the three and ~~six~~nine months ended ~~April~~July 1, 2023 ~~was 14.6%~~were 9.1% and 13.8%, respectively, compared to the effective tax ~~rates~~rate of ~~14.2% and~~ 13.4% for the three and ~~six~~nine months ended ~~April~~July 2, ~~2022, respectively.~~2022. The ~~increases in effective tax rates~~decrease for the three ~~and six~~ months ended ~~April~~July 1, 2023 compared to the three ~~and six~~ months ended ~~April~~July 2, 2022 ~~were~~was primarily due to ~~a change~~an increase in discrete tax benefits of $3.0 million. The increase for the ~~geographic distribution of pre-tax book income.~~nine months ended July 1, 2023 compared to the nine months ended July 2, 2022 was primarily due to a

Table of Contents

change in the geographic distribution of pre-tax book income, partially offset by an increase in discrete tax benefits of $3.2 million.

The amount of unrecognized tax benefits recorded for uncertain tax positions increased by ~~$0.9~~$3.5 million for the three months ended ~~April~~July 1, 2023. The Company recognizes accrued interest and penalties on uncertain tax positions as a component of income tax expense. The amount of interest and penalties recorded for the three and ~~six~~nine months ended ~~April~~July 1, 2023 was $0.2 million and ~~$0.3~~$0.5 million, respectively.

One or more uncertain tax positions may be settled within the next 12 months. Settlement of these matters is not expected to have a material effect on the Company's consolidated results of operations, financial position and cash flows. The Company is not currently under examination by taxing authorities in the U.S. The Company is under audit in a foreign jurisdiction but any settlement is not expected to have a material impact.

The Company maintains valuation allowances when it is more likely than not that all or a portion of a net deferred tax asset will not be realized. During the three months ended ~~April~~July 1, 2023, the Company continued to record a full valuation allowance against its net deferred tax assets in certain jurisdictions within the EMEA segment and a partial valuation against its net deferred tax assets in certain jurisdictions within the AMER segment, as it was more likely than not that these assets would not be fully realized based primarily on historical performance. The Company will continue to provide a valuation allowance against its net deferred tax assets in each of the applicable jurisdictions going forward until it determines it is more likely than not that the deferred tax assets will be realized.

6. Earnings Per Share

The following is a reconciliation of the amounts utilized in the computation of basic and diluted earnings per share for the three and ~~six~~nine months ended ~~April~~July 1, 2023 and ~~April~~July 2, 2022 (in thousands, except per share amounts):


		Three Months Ended				Six Months Ended					Three Months Ended				Nine Months Ended
		April 1, 2023		April 2, 2022		April 1, 2023		April 2, 2022			July 1, 2023		July 2, 2022		July 1, 2023		July 2, 2022
Net income	Net income	$	40,844	$	26,869	$	83,034	$	50,292	Net income	$	15,799	$	37,494	$	98,833	$	87,786
Basic weighted average common shares outstanding	Basic weighted average common shares outstanding	27,661		27,987		27,650		28,002		Basic weighted average common shares outstanding	27,561		27,738		27,619		27,913
Dilutive effect of share-based awards and options outstanding	Dilutive effect of share-based awards and options outstanding	523		440		623		564		Dilutive effect of share-based awards and options outstanding	431		441		550		539
Diluted weighted average shares outstanding	Diluted weighted average shares outstanding	28,184		28,427		28,273		28,566		Diluted weighted average shares outstanding	27,992		28,179		28,169		28,452
Earnings per share:	Earnings per share:									Earnings per share:
Basic	Basic	$	1.48	$	0.96	$	3.00	$	1.80	Basic	$	0.57	$	1.35	$	3.58	$	3.14
Diluted	Diluted	$	1.45	$	0.95	$	2.94	$	1.76	Diluted	$	0.56	$	1.33	$	3.51	$	3.09

For the three and ~~six~~nine months ended ~~April~~July 1, 2023 and ~~April~~July 2, 2022, share-based awards for less than 0.1 million shares were not included in the computation of diluted earnings per share as they were antidilutive.

See also Note 12, "Shareholders' Equity," for information regarding the Company's share repurchase plans.

Table of Contents

7. Leases

The components of lease expense for the three and ~~six~~nine months ended ~~April~~July 1, 2023 and ~~April~~July 2, 2022 indicated were as follows (in thousands):

Three Months Ended Six Months Ended
April 1,
2023 April 2,
2022 April 1,
2023 April 2,
2022
Finance lease expense:
Amortization of right-of-use assets $ 1,952 $ 1,667 $ 3,566 $ 3,360
Interest on lease liabilities 1,260 1,229 2,532 2,451
Operating lease expense 2,736 2,838 5,342 5,695
Other lease expense 1,830 1,443 3,596 2,847
Total $ 7,778 $ 7,177 $ 15,036 $ 14,353

~~Table of Contents~~


	Three Months Ended				Nine Months Ended
	July 1, 2023		July 2, 2022		July 1, 2023		July 2, 2022
Finance lease expense:
Amortization of right-of-use assets	$	1,668	$	1,606	$	5,234	$	4,966
Interest on lease liabilities	1,302		1,262		3,834		3,713
Operating lease expense	2,696		2,912		8,038		8,607
Other lease expense	2,345		1,712		5,941		4,559
Total	$	8,011	$	7,492	$	23,047	$	21,845

Based on the nature of the ~~right-of use~~right-of-use ("ROU") asset, amortization of finance lease ROU assets, operating lease expense and other lease expense are recorded within either cost of goods sold or selling and administrative expenses and interest on finance lease liabilities is recorded within interest expense on the Condensed Consolidated Statements of Comprehensive Income. Other lease expense includes lease expense for leases with an estimated total term of twelve months or less and variable lease expense related to variations in lease payments as a result of a change in factors or circumstances occurring after the lease possession date.

The following ~~tables~~table sets forth the amount of lease assets and lease liabilities included in the Company’s Condensed Consolidated Balance Sheets (in thousands):


		Financial Statement Line Item	April 1, 2023		October 1, 2022			Financial Statement Line Item	July 1, 2023		October 1, 2022
ASSETS	ASSETS						ASSETS
Finance lease assets	Finance lease assets	Property, plant and equipment, net	$	40,869	$	40,063	Finance lease assets	Property, plant and equipment, net	$	37,511	$	40,063
Operating lease assets	Operating lease assets	Operating lease right-of-use assets	62,795		65,134		Operating lease assets	Operating lease right-of-use assets	71,914		65,134
Total lease assets	Total lease assets		$	103,664	$	105,197	Total lease assets		$	109,425	$	105,197

LIABILITIES AND SHAREHOLDERS' EQUITY	LIABILITIES AND SHAREHOLDERS' EQUITY						LIABILITIES AND SHAREHOLDERS' EQUITY
Current	Current						Current
Finance lease liabilities	Finance lease liabilities	Current portion of long-term debt and finance lease obligations	$	6,645	$	5,087	Finance lease liabilities	Current portion of long-term debt and finance lease obligations	$	5,969	$	5,087
Operating lease liabilities	Operating lease liabilities	Other accrued liabilities	8,358		7,948		Operating lease liabilities	Other accrued liabilities	8,772		7,948
Non-current	Non-current						Non-current
Finance lease liabilities	Finance lease liabilities	Long-term debt and finance lease obligations, net of current portion	40,013		39,257		Finance lease liabilities	Long-term debt and finance lease obligations, net of current portion	38,731		39,257
Operating lease liabilities	Operating lease liabilities	Long-term operating lease liabilities	31,257		33,628		Operating lease liabilities	Long-term operating lease liabilities	40,515		33,628
Total lease liabilities	Total lease liabilities		$	86,273	$	85,920	Total lease liabilities		$	93,987	$	85,920

8. Share-Based Compensation

The Company recognized ~~$5.9~~$3.9 million and ~~$11.7~~$15.6 million of compensation expense associated with share-based awards for the three and ~~six~~nine months ended ~~April~~July 1, 2023, respectively, and ~~$6.1~~$6.0 million and ~~$12.4~~$18.2 million for the three and ~~six~~nine months ended ~~April~~July 2, 2022, respectively.

Table of Contents

9. Litigation

The Company is party to lawsuits in the ordinary course of business. We record provisions in the consolidated financial statements for pending legal matters when we determine that an unfavorable outcome is probable, and the amount of the loss can be reasonably estimated. ~~For matters we have~~

In June 2023, the Company paid a one-time, non-recurring payment of $15.8 million related to an arbitration decision in Norway regarding a contractual matter concluded in May 2023. This payment resulted in a $14.2 million one-time, non-recurring charge, net of insurance recoveries and amounts previously accrued. The Company no longer provides services for this customer. Refer to Note 15, "Restructuring and Non-recurring Charges," for information regarding total charges. The Company does not ~~provided for that are reasonably possible~~expect further charges relating to ~~result in an unfavorable outcome, management~~this matter, but is ~~unable to estimate the possible loss or range of loss or such amounts have been determined to be immaterial. Currently, management~~pursuing further insurance recoveries.

Management does not believe that any other such proceedings, individually or in the aggregate, will have a material positive or adverse effect on the Company’s consolidated financial position, results of operations or cash flows. However, legal proceedings and regulatory and governmental matters are subject to inherent uncertainties, and unfavorable rulings or other events could occur. Unfavorable resolutions could involve substantial fines, civil or criminal penalties, and other expenditures.

10. Reportable Segments

Reportable segments are defined as components of an enterprise about which separate financial information is available that is evaluated regularly by the chief operating decision maker, or group, in assessing performance and allocating resources. The Company uses an internal management reporting system, which provides important financial data to evaluate performance and allocate the Company’s resources on a regional basis. Net sales for the segments are attributed to the region in which the product is manufactured or the service is performed. The services provided, manufacturing processes used, class of customers

~~Table of Contents~~

serviced and order fulfillment processes used are similar and generally interchangeable across the segments. A segment’s performance is evaluated based upon its operating income. A segment’s operating income includes its net sales less cost of sales and selling and administrative expenses but excludes corporate and other expenses. Corporate and other expenses primarily represent corporate selling and administrative expenses, and restructuring costs and other charges, if any. These costs are not allocated to the segments, as management excludes such costs when assessing the performance of the segments. Inter-segment transactions are generally recorded at amounts that approximate arm’s length transactions. The accounting policies for the segments are the same as for the Company taken as a whole.

Table of Contents

Information about the Company’s three reportable segments for the three and ~~six~~nine months ended ~~April~~July 1, 2023 and ~~April~~July 2, 2022 is as follows (in thousands):


		Three Months Ended				Six Months Ended					Three Months Ended				Nine Months Ended
		April 1, 2023		April 2, 2022		April 1, 2023		April 2, 2022			July 1, 2023		July 2, 2022		July 1, 2023		July 2, 2022
Net sales:	Net sales:									Net sales:
AMER	AMER	$	407,806	$	311,205	$	797,468	$	588,551	AMER	$	371,358	$	342,572	$	1,168,826	$	931,123
APAC	APAC	587,270		533,885		1,229,174		1,025,557		APAC	572,150		586,305		1,801,324		1,611,862
EMEA	EMEA	101,794		73,702		191,167		146,565		EMEA	104,385		84,177		295,552		230,742
Elimination of inter-segment sales	Elimination of inter-segment sales	(26,047)		(30,069)		(53,061)		(54,494)		Elimination of inter-segment sales	(26,283)		(31,713)		(79,344)		(86,207)
		$	1,070,823	$	888,723	$	2,164,748	$	1,706,179		$	1,021,610	$	981,341	$	3,186,358	$	2,687,520

Operating income:	Operating income:									Operating income:
AMER	AMER	$	25,767	$	7,769	$	43,182	$	9,559	AMER	$	15,927	$	16,976	$	59,109	$	26,535
APAC	APAC	69,728		60,860		148,134		121,548		APAC	69,836		67,286		217,970		188,834
EMEA	EMEA	1,879		490		1,240		1,446		EMEA	783		2,597		2,023		4,043
Corporate and other costs	Corporate and other costs	(40,432)		(33,282)		(78,273)		(66,243)		Corporate and other costs	(58,342)		(37,298)		(136,615)		(103,541)
		56,942		35,837		114,283		66,310			28,204		49,561		142,487		115,871
Other income (expense):	Other income (expense):									Other income (expense):
Interest expense	Interest expense	(8,287)		(3,345)		(15,181)		(6,391)		Interest expense	(8,231)		(3,923)		(23,412)		(10,314)
Interest income	Interest income	759		262		1,693		533		Interest income	598		318		2,291		851
Miscellaneous, net	Miscellaneous, net	(1,612)		(1,446)		(3,556)		(2,369)		Miscellaneous, net	(3,194)		(2,678)		(6,750)		(5,047)
Income before income taxes	Income before income taxes	$	47,802	$	31,308	$	97,239	$	58,083	Income before income taxes	$	17,377	$	43,278	$	114,616	$	101,361


		April 1, 2023		October 1, 2022			July 1, 2023		October 1, 2022
Total assets:	Total assets:					Total assets:
AMER	AMER	$	1,161,745	$	1,150,605	AMER	$	1,169,505	$	1,150,605
APAC	APAC	1,770,318		1,807,542		APAC	1,785,748		1,807,542
EMEA	EMEA	371,313		302,901		EMEA	429,305		302,901
Corporate and eliminations	Corporate and eliminations	78,644		132,177		Corporate and eliminations	34,385		132,177
		$	3,382,020	$	3,393,225		$	3,418,943	$	3,393,225

11. Guarantees

The Company offers certain indemnifications under its customer manufacturing agreements. In the normal course of business, the Company may from time to time be obligated to indemnify its customers or its customers’ customers against damages or liabilities arising out of the Company’s negligence, misconduct, breach of contract, or infringement of third-party intellectual property rights. Certain agreements have extended broader indemnification, and while most agreements have contractual limits, some do not. However, the Company generally does not provide for such indemnities and seeks indemnification from its customers for damages or liabilities arising out of the Company’s adherence to customers’ specifications or designs or use of

~~Table of Contents~~

materials furnished, or directed to be used, by its customers. The Company does not believe its obligations under such indemnities are material.

In the normal course of business, the Company also provides its customers a limited warranty covering workmanship, and in some cases materials, on products manufactured by the Company. Such warranty generally provides that products will be free from defects in the Company’s workmanship and meet mutually agreed-upon specifications for periods generally ranging from 12 months to 24 months. The Company’s obligation is generally limited to correcting, at its expense, any defect by repairing or replacing such defective product. The Company’s warranty generally excludes defects resulting from faulty customer-supplied components, design defects or damage caused by any party or cause other than the Company.

Table of Contents

The Company provides ~~for~~ an estimate of costs that may be incurred under its limited warranty at the time product revenue is recognized and establishes additional reserves for specifically identified product issues. These costs primarily include labor and materials, as necessary, associated with repair or replacement and are included in the Company's accompanying Condensed Consolidated Balance Sheets in "other accrued liabilities." The primary factors that affect the Company’s warranty liability include the value and the number of shipped units and historical and anticipated rates of warranty claims. As these factors are impacted by actual experience and future expectations, the Company assesses the adequacy of its recorded warranty liabilities and adjusts the amounts as necessary.

Below is a table summarizing the activity related to the Company’s limited warranty liability for the ~~six~~nine months ended ~~April~~July 1, 2023 and ~~April~~July 2, 2022 (in thousands):


		Six Months Ended					Nine Months Ended
		April 1, 2023		April 2, 2022			July 1, 2023		July 2, 2022
Reserve balance, beginning of period	Reserve balance, beginning of period	$	6,925	$	6,645	Reserve balance, beginning of period	$	6,925	$	6,645
Accruals for warranties issued during the period	Accruals for warranties issued during the period	1,254		1,885		Accruals for warranties issued during the period	2,027		2,431
Settlements (in cash or in kind) during the period	Settlements (in cash or in kind) during the period	(2,243)		(1,193)		Settlements (in cash or in kind) during the period	(3,467)		(2,032)
Reserve balance, end of period	Reserve balance, end of period	$	5,936	$	7,337	Reserve balance, end of period	$	5,485	$	7,044

12. Shareholders' Equity

On August 11, 2021, the Board of Directors approved a share repurchase program under which the Company was authorized to repurchase up to $50.0 million of its common stock (the "2022 Program"). The 2022 Program commenced upon completion of the 2021 Program and was completed in fiscal 2022. During the three months ended ~~April~~July 2, 2022, the Company repurchased ~~305,707~~148,571 shares under this program for ~~$25.0~~$11.7 million at an average price of ~~$81.79~~$79.27 per share. During the ~~six~~nine months ended ~~April~~July 2, 2022, the Company repurchased ~~416,147~~564,718 shares under this program for ~~$35.2~~$46.9 million at an average price of ~~$84.43~~$83.07 per share.

On August 18, 2022, the Board of Directors approved a share repurchase program under which the Company is authorized to repurchase up to $50.0 million of its common stock (the "2023 Program"). The 2023 Program became effective immediately and has no expiration. During the three months ended ~~April~~July 1, 2023, the Company repurchased ~~125,639~~149,783 shares under this program for ~~$12.4~~$13.5 million at an average price of ~~$98.75~~$90.49 per share. During the ~~six~~nine months ended ~~April~~July 1, 2023, the Company repurchased ~~241,362~~391,145 shares under this program for ~~$23.9~~$37.4 million at an average price of ~~$98.93~~$95.70 per share. As of ~~April~~July 1, 2023, ~~$22.6~~$9.1 million of the 2023 Program remained available to repurchase shares.

All shares repurchased under the aforementioned programs were recorded as treasury stock.

13. Trade Accounts Receivable Sale Programs

The Company has Master Accounts Receivable Purchase Agreements with MUFG Bank, New York Branch (formerly known as The Bank of Tokyo-Mitsubishi UFJ, Ltd.) (the "MUFG RPA"), HSBC Bank (China) Company Limited, Xiamen branch (the "HSBC RPA") and other unaffiliated financial institutions, under which the Company may elect to sell receivables; at a discount. All facilities are uncommitted facilities. The maximum facility amount under the MUFG RPA is $340.0 million. The maximum facility amount under the HSBC RPA is $60.0 million. The MUFG RPA will be automatically extended each year unless any party gives no less than 10 days prior notice that the agreement should not be extended. The terms of the HSBC RPA are generally consistent with the terms of the MUFG RPA.

~~Table of Contents~~

Transfers of receivables under the programs are accounted for as sales and, accordingly, receivables sold under the programs are excluded from accounts receivable on the Condensed Consolidated Balance Sheets and are reflected as cash provided by operating activities on the Condensed Consolidated Statements of Cash Flows. Proceeds from the transfer reflect the face value of the receivables less a discount. The sale discount is recorded within "Miscellaneous, net" in the Condensed Consolidated Statements of Comprehensive Income in the period of the sale. The Company continues servicing receivables sold and performing all accounts receivable administrative functions, and in exchange receives a servicing fee, under both the MUFG RPA and HSBC RPA. Servicing fees related to trade accounts receivable programs recognized during the three and ~~six~~nine months ended ~~April~~July 1, 2023 and ~~April~~July 2, 2022 were not material.

Table of Contents

The Company sold ~~$225.7~~$205.3 million and ~~$202.2~~$213.6 million of trade accounts receivable under these programs, or their predecessors, during the three months ended ~~April~~July 1, 2023 and ~~April~~July 2, 2022, respectively, in exchange for cash proceeds of ~~$222.9~~$202.9 million and $~~201.5~~212.3 million, respectively.

The Company sold ~~$411.3~~$616.6 million and ~~$350.2~~$563.8 million of trade accounts receivable under these programs, or their predecessors, during the ~~six~~nine months ended ~~April~~July 1, 2023 and ~~April~~July 2, 2022, respectively, in exchange for cash proceeds of ~~$406.5~~$609.4 million and $~~349.0~~561.3 million, respectively.

As of ~~April~~July 1, 2023 and October 1, 2022, ~~$233.4~~$216.8 million and $222.5 million, respectively, of accounts receivables sold under trade accounts receivable programs and subject to servicing by the Company remained outstanding and had not yet been collected.

14. Revenue from Contracts with Customers

Revenue is recognized over time for arrangements with customers for which: (i) the Company's performance does not create an asset with an alternative use to the Company, and (ii) the Company has an enforceable right to payment, including reasonable profit margin, for performance completed to date. Revenue recognized over time is estimated based on costs incurred to date plus a reasonable profit margin. If either of the two conditions noted above are not met to recognize revenue over time, revenue is recognized following the transfer of control of such products to the customer, which typically occurs upon shipment or delivery depending on the terms of the underlying arrangement.

The Company recognizes revenue when a contract exists and when, or as, it satisfies a performance obligation by transferring control of a product or service to a customer. Contracts are accounted for when they have approval and commitment from both parties, the rights of the parties are identified, payment terms are identified, the contract has commercial substance and collectability of consideration is probable. A performance obligation is a promise in a contract to transfer a distinct good or service to the customer.

The Company generally enters into a master services arrangement that establishes the framework under which business will be conducted. These arrangements represent the master terms and conditions of the Company's services that apply to individual orders, but they do not commit the customer to work with, or to continue to work with, the Company nor do they obligate the customer to any specific volume or pricing of purchases. Moreover, these terms can be amended in appropriate situations.

Customer purchase orders are received for specific quantities with predominantly fixed pricing and delivery requirements. Thus, for the majority of our contracts, there is no guarantee of any revenue to the Company until a customer submits a purchase order. As a result, the Company generally considers its arrangement with a customer to be the combination of the master services arrangement and the purchase order. Most of the Company's arrangements with customers create a single performance obligation as the promise to transfer the individual manufactured product or service is capable of being distinct.

The Company’s performance obligations are satisfied over time as work progresses or at a point in time. A performance obligation is satisfied over time if the Company has an enforceable right to payment, including a reasonable profit margin. Determining if an enforceable right to payment includes a reasonable profit margin requires judgment and is assessed on a contract by contract basis.

Generally, there are no subjective customer acceptance requirements or further obligations related to goods or services provided; if such requirements or obligations exist, then a sale is recognized at the time when such requirements are completed and such obligations are fulfilled.

The Company does not allow for a general right of return. Net sales include amounts billed to customers for shipping and handling and out-of-pocket expenses. The corresponding shipping and handling costs and out-of-pocket expenses are included

~~Table of Contents~~

in cost of sales. Taxes assessed by a governmental authority that are both imposed on and concurrent with a specific revenue-producing transaction, that are collected by the Company from a customer, are excluded from net sales.

Contract Costs

For contracts requiring over time revenue recognition, the selection of the method to measure progress towards completion requires judgment and is based on the nature of the products or services to be provided. The Company uses a cost-based input measurement of progress because it best depicts the transfer of assets to the customer, which occurs as costs are incurred during the manufacturing process or as services are rendered. Under the cost-based measure of progress, the extent of progress towards completion is measured based on the costs incurred to date.

There were no other costs to obtain or fulfill customer contracts.

~~Disaggregated Revenue~~

The table below includes the Company’s revenue for the three and six months ended April 1, 2023 and April 2, 2022 indicated disaggregated by geographic reportable segment and market sector (in thousands):

Three Months Ended
April 1, 2023
Reportable Segment:
AMER APAC EMEA Total
Market Sector:
Industrial $ 98,686 $ 312,840 $ 27,755 $ 439,281
Healthcare/Life Sciences 228,245 206,442 52,683 487,370
Aerospace/Defense 76,731 47,445 19,996 144,172
External revenue 403,662 566,727 100,434 1,070,823
Inter-segment sales 4,144 20,543 1,360 26,047
Segment revenue $ 407,806 $ 587,270 $ 101,794 $ 1,096,870

Three Months Ended
April 2, 2022
Reportable Segment:
AMER APAC EMEA Total
Market Sector:
Industrial $ 98,267 $ 302,326 $ 14,061 $ 414,654
Healthcare/Life Sciences 143,855 165,099 44,294 353,248
Aerospace/Defense 67,213 38,923 14,685 120,821
External revenue 309,335 506,348 73,040 888,723
Inter-segment sales 1,870 27,537 662 30,069
Segment revenue $ 311,205 $ 533,885 $ 73,702 $ 918,792

Table of Contents

Six Months Ended
April 1, 2023
Reportable Segment:
AMER APAC EMEA Total
Market Sector:
Industrial $ 201,713 $ 663,424 $ 46,226 $ 911,363
Healthcare/Life Sciences 443,626 429,732 101,879 975,237
Aerospace/Defense 144,753 93,099 40,296 278,148
External revenue 790,092 1,186,255 188,401 2,164,748
Inter-segment sales 7,376 42,919 2,766 53,061
Segment revenue $ 797,468 $ 1,229,174 $ 191,167 $ 2,217,809
Disaggregated Revenue

The table below includes disaggregated revenue by geographic reportable segment and market sector for the three and nine months ended July 1, 2023 and July 2, 2022 (in thousands):


	Three Months Ended
	July 1, 2023
	Reportable Segment:
	AMER		APAC		EMEA		Total
Market Sector:
Industrial	$	97,527	$	300,258	$	29,928	$	427,713
Healthcare/Life Sciences	205,496		193,740		51,764		451,000
Aerospace/Defense	63,409		57,785		21,703		142,897
External revenue	366,432		551,783		103,395		1,021,610
Inter-segment sales	4,926		20,367		990		26,283
Segment revenue	$	371,358	$	572,150	$	104,385	$	1,047,893


		Six Months Ended									Three Months Ended
		April 2, 2022									July 2, 2022
		Reportable Segment:									Reportable Segment:
		AMER		APAC		EMEA		Total			AMER		APAC		EMEA		Total
Market Sector:	Market Sector:									Market Sector:
Industrial	Industrial	$	181,512	$	567,601	$	29,368	$	778,481	Industrial	$	108,064	$	328,314	$	17,999	$	454,377
Healthcare/Life Sciences	Healthcare/Life Sciences	279,817		334,336		83,560		697,713		Healthcare/Life Sciences	171,697		184,202		44,900		400,799
Aerospace/Defense	Aerospace/Defense	122,963		74,666		32,356		229,985		Aerospace/Defense	59,972		45,980		20,213		126,165
External revenue	External revenue	584,292		976,603		145,284		1,706,179		External revenue	339,733		558,496		83,112		981,341
Inter-segment sales	Inter-segment sales	4,259		48,954		1,281		54,494		Inter-segment sales	2,839		27,809		1,065		31,713
Segment revenue	Segment revenue	$	588,551	$	1,025,557	$	146,565	$	1,760,673	Segment revenue	$	342,572	$	586,305	$	84,177	$	1,013,054


	Nine Months Ended
	July 1, 2023
	Reportable Segment:
	AMER		APAC		EMEA		Total
Market Sector:
Industrial	$	299,240	$	963,682	$	76,154	$	1,339,076
Healthcare/Life Sciences	649,122		623,472		153,643		1,426,237
Aerospace/Defense	208,162		150,884		61,999		421,045
External revenue	1,156,524		1,738,038		291,796		3,186,358
Inter-segment sales	12,302		63,286		3,756		79,344
Segment revenue	$	1,168,826	$	1,801,324	$	295,552	$	3,265,702

Table of Contents


	Nine Months Ended
	July 2, 2022
	Reportable Segment:
	AMER		APAC		EMEA		Total
Market Sector:
Industrial	$	289,576	$	895,915	$	47,367	$	1,232,858
Healthcare/Life Sciences	451,514		518,538		128,460		1,098,512
Aerospace/Defense	182,935		120,646		52,569		356,150
External revenue	924,025		1,535,099		228,396		2,687,520
Inter-segment sales	7,098		76,763		2,346		86,207
Segment revenue	$	931,123	$	1,611,862	$	230,742	$	2,773,727

For the three and ~~six~~nine months ended ~~April~~July 1, 2023, approximately ~~80%~~83% and 81% of the Company's revenue, respectively, was recognized as products and services were transferred over time. For the three and ~~six~~nine months ended ~~April~~July 2, 2022, approximately ~~85%~~83% and ~~86%~~85% of the Company's revenue, respectively, was recognized as products and services were transferred over time.

Contract Balances

The timing of revenue recognition, billings and cash collections results in billed accounts receivable, contract assets and deferred revenue on the Company’s accompanying Condensed Consolidated Balance Sheets.

Contract Assets: For performance obligations satisfied at a point in time, billing occurs subsequent to revenue recognition, at which point the customer has been billed and the resulting asset is recorded within accounts receivable. For performance obligations satisfied over time as work progresses, the Company has an unconditional right to payment, which results in the recognition of contract assets. The following table summarizes the activity in the Company's contract assets during the ~~six~~nine months ended ~~April~~July 1, 2023 and ~~April~~July 2, 2022 (in thousands):


		Six Months Ended					Nine Months Ended
		April 1, 2023		April 2, 2022			July 1, 2023		July 2, 2022
Contract assets, beginning of period	Contract assets, beginning of period	$	138,540	$	115,283	Contract assets, beginning of period	$	138,540	$	115,283
Revenue recognized during the period	Revenue recognized during the period	1,743,054		1,460,802		Revenue recognized during the period	2,589,181		2,279,559
Amounts collected or invoiced during the period	Amounts collected or invoiced during the period	(1,748,565)		(1,459,998)		Amounts collected or invoiced during the period	(2,594,726)		(2,266,792)
Contract assets, end of period	Contract assets, end of period	$	133,029	$	116,087	Contract assets, end of period	$	132,995	$	128,050

Deferred Revenue: Deferred revenue is recorded when consideration is received from a customer prior to transferring goods or services to the customer under the terms of the contract, which is included in other accrued liabilities on the Condensed Consolidated Balance Sheets. As of ~~April~~July 1, 2023 and October 1, 2022 the balance of advance payments from customers was

~~Table of Contents~~

~~$228.7~~ $215.7 million and $298.8 million, respectively. The advance payment is not considered a significant financing component because it is used to meet working capital demands that can be higher in the early stages of a contract and to protect the company from the other party failing to adequately complete some or all of its obligations under the contract. Deferred revenue is recognized into revenue when all revenue recognition criteria are met. For performance obligations satisfied over time, recognition will occur as work progresses; otherwise deferred revenue will be recognized based upon shipping terms.

15. Restructuring and ~~Impairment~~Non-recurring Charges

Restructuring and ~~impairment~~non-recurring charges are recorded within restructuring and ~~impairment~~other charges on the Condensed Consolidated Statements of Comprehensive Income. Restructuring liabilities are primarily recorded within other accrued liabilities on the Condensed Consolidated Balance Sheets.

For the three and ~~six~~nine months ended ~~April~~July 1, 2023, the Company incurred restructuring and other charges of $8.9 million, which consisted of severance from the reduction of the Company's workforce and a lease agreement termination. Additionally, the

Table of Contents

Company incurred a one-time, non-recurring charge of $14.2 million relating to an arbitration decision in Norway regarding a contractual matter. The Company no longer provides services for this customer.

For the three months ended July 2, 2022, the Company did not incur any restructuring and impairment charges.

For the ~~three~~nine months ended ~~April 2, 2022, the company did not incur any restructuring and impairment charges. For the six months ended April~~July 2, 2022, the Company recorded $2.0 million of restructuring and impairment charges primarily due to employee severance costs associated with a facility transition in the Company's APAC segment.

The Company recognized a tax benefit of $1.8 million related to restructuring and other charges for the three and nine months ended July 1, 2023 and $0.2 million related to restructuring and impairment charges for the ~~six~~nine months ended ~~April~~July 2, 2022.

The Company's restructuring accrual activity for the three and ~~six~~nine months ended ~~April~~July 1, 2023 and nine months ended July 2, 2022 is included in the tables below (in thousands):

Fixed Asset and Operating ROU Asset Impairment Employee Termination and Severance Costs Total
Accrual balance, as of October 2, 2021 $ — $ 71 $ 71
Restructuring and impairment costs 255 1,766 2,021
Amounts utilized (255) (75) (330)
Accrual balance, as of January 1, 2022 $ — $ 1,762 $ 1,762
Restructuring and impairment costs — — —
Amounts utilized — (100) (100)
Accrual balance, as of April 2, 2022 $ — $ 1,662 $ 1,662


	Arbitration Charge		Termination and Severance Costs		Total
Accrual balance, as of April 1, 2023	$	—	$	—	$	—
Restructuring and other charges	14,229		8,865		23,094
Amounts utilized	(14,753)		(5,332)		(20,085)
Accrual balance, as of July 1, 2023	$	(524)	$	3,533	$	3,009


	Fixed Asset and Operating ROU Asset Impairment		Termination and Severance Costs		Total
Accrual balance, as of October 2, 2021	$	—	$	71	$	71
Restructuring and impairment costs	255		1,766		2,021
Amounts utilized	(255)		(75)		(330)
Accrual balance, as of January 1, 2022	$	—	$	1,762	$	1,762
Restructuring and impairment costs	—		—		—
Amounts utilized	—		(100)		(100)
Accrual balance, as of April 2, 2022	$	—	$	1,662	$	1,662
Restructuring and impairment costs	—		—		—
Amounts utilized	—		(181)		(181)
Accrual balance, as of July 2, 2022	$	—	$	1,481	$	1,481

The accrual balances outstanding as of ~~April~~July 2, 2022 were fully utilized as of ~~April~~July 1, 2023.

~~16. Subsequent Event~~

During April 2023, the Company committed to a restructuring plan and anticipates incurring approximately $9.0 million of restructuring and other non-recurring costs during the third quarter of fiscal 2023.

1819

Table of Contents

ITEM 2. MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS

"SAFE HARBOR" CAUTIONARY STATEMENT UNDER THE PRIVATE SECURITIES LITIGATION REFORM ACT OF 1995:

The statements contained in this Form 10-Q that are guidance or which are not historical facts (such as statements in the future tense and statements including believe, expect, intend, plan, anticipate, goal, target and similar terms and concepts), including all discussions of periods which are not yet completed, are forward-looking statements that involve risks and uncertainties. These risks and uncertainties include the effect of inflationary pressures on our costs of production, profitability, and on the economic outlook of our markets; the effects of shortages and delays in obtaining components as a result of economic cycles, natural disasters or otherwise; the risk of customer delays, changes, cancellations or forecast inaccuracies in both ongoing and new programs; the ability to realize anticipated savings from restructuring or similar actions, as well as the adequacy of related charges as compared to actual expenses; the lack of visibility of future orders, particularly in view of changing economic conditions; the economic performance of the industries, sectors and customers we serve; the outcome of litigation and regulatory ~~investigations;~~investigations and proceedings, including the results of any challenges with regard to such outcomes; the effects of tariffs, trade disputes, trade agreements and other trade protection measures; the effects of the volume of revenue from certain sectors or programs on our margins in particular periods; our ability to secure new customers, maintain our current customer base and deliver product on a timely basis; the risks of concentration of work for certain customers; the particular risks relative to new or recent customers, programs or services, which risks include customer and other delays, start-up costs, potential inability to execute, the establishment of appropriate terms of agreements, and the lack of a track record of order volume and timing; the effects of start-up costs of new programs and facilities or the costs associated with the closure or consolidation of facilities; possible unexpected costs and operating disruption in transitioning programs, including transitions between Company facilities; the risk that new program wins and/or customer demand may not result in the expected revenue or profitability; the fact that customer orders may not lead to long-term relationships; our ability to manage successfully and execute a complex business model characterized by high product mix and demanding quality, regulatory, and other requirements; the risks associated with excess and obsolete inventory, including the risk that inventory purchased on behalf of our customers may not be consumed or otherwise paid for by the customer, resulting in an inventory write-off; risks related to information technology systems and data security; increasing regulatory and compliance requirements; any tax law changes and related foreign jurisdiction tax developments; current or potential future barriers to the repatriation of funds that are currently held outside of the United States as a result of actions taken by other countries or otherwise; the potential effects of jurisdictional results on our taxes, tax rates, and our ability to use deferred tax assets and net operating losses; the weakness of areas of the global economy; the effect of changes in the pricing and margins of products; raw materials and component cost fluctuations; the potential effect of fluctuations in the value of the currencies in which we transact business; the effects of changes in economic conditions, political conditions and tax matters in the United States and in the other countries in which we do business; the potential effect of other world or local events or other events outside our control (such as the conflict between Russia and Ukraine, escalating tensions between China and Taiwan or China and the United States, changes in energy prices, terrorism, global health epidemics and weather events); the impact of increased competition; an inability to successfully manage human capital; changes in financial accounting standards; and other risks detailed herein and in our other Securities and Exchange Commission filings, particularly in Risk Factors contained in our fiscal 2022 Form 10-K.

* * *

1920

Table of Contents

OVERVIEW

Plexus Corp. and its subsidiaries (together "Plexus," the "Company", "our", or "we") participate in the Electronic Manufacturing Services ("EMS") industry. Since 1979, we have been partnering with companies to create the products that build a better world. We are a global leader with a team of nearly 25,000 individuals who are dedicated to providing Design and Development, Supply Chain Solutions, New Product Introduction, Manufacturing and Sustaining Services. We specialize in serving customers in industries with highly complex products and demanding regulatory environments. We deliver customer service excellence to leading global companies in the Industrial, Healthcare/Life Sciences and Aerospace/Defense market sectors by providing innovative, comprehensive solutions throughout the product's lifecycle. We provide these innovative solutions to customers in the Americas ("AMER"), Asia-Pacific ("APAC") and Europe, Middle East and Africa ("EMEA") regions.

The following Management's Discussion and Analysis of Financial Condition and Results of Operations ("MD&A") is intended to provide an analysis of both short-term results and future prospects from management’s perspective, including an assessment of the financial condition and results of operations, events and uncertainties that are not indicative of future operations and any other financial or statistical data that we believe will enhance the understanding of our company’s financial condition, cash flows and other changes in financial condition and results of operations.

The following information should be read in conjunction with our condensed consolidated financial statements included herein and "Risk Factors" included in Part II, Item 1A included herein as well as Part I, Item 1A of our Annual Report on Form 10-K for the fiscal year ended October 1, 2022, and our "Safe Harbor" Cautionary Statement included above.

Market Pressures Update

We have experienced an inability to procure certain components on a timely basis due to global supply chain constraints. These constraints have impacted our ability to meet customer demand and may inhibit our ability to capture the demand from our customers. The extended lead-times have required us to make additional investments in inventory to satisfy customer demand, which we expect to persist.

Over the past ~~few quarters,~~year, the global supply chain constraints have led to inflation in some of the components we acquire, as well as labor and operating costs. We have also been, and expect to continue to be, subject to such inflationary and general labor cost increases. ~~We expect the increase in costs, including labor-related issues, to continue in the near future.~~ While we have been largely able to mitigate the impacts of inflation through our contractual rights with customers on pricing, the pricing recoveries received may be dilutive to our operating margin. The inability to offset these costs in future periods or the impacts of continued inflation on end markets and our customers may affect our operating results, cash flows and inventory levels, which could increase as a result of higher component prices or the negative effects of inflation on customer end-market demand.

The Department of Commerce’s export controls restricting the People’s Republic of China’s access to advanced semiconductors, supercomputers, and semiconductor manufacturing equipment has created demand volatility for some of our customers as they adjust their forecasts as a result of these restrictions, which can create operating inefficiencies that may place additional burden on our operating results.

Changes in tax laws or tax rates in the jurisdictions where we operate, including the potential passage of tax regulation changes such as the establishment of a global minimum tax could result in adverse tax consequences. During the first ~~six~~nine months of fiscal 2023, certain jurisdictions consented to implement a global minimum tax. We will continue to monitor these developments as each jurisdiction incorporates such changes into tax laws.

In June 2023, we paid a one-time, non-recurring payment of $15.8 million related to an arbitration decision in Norway regarding a contractual matter concluded upon in May 2023. Refer to Note 15, "Restructuring and Non-recurring Charges," for information regarding total charges. We no longer provide services for this customer and do not expect further charges relating to this matter, but are pursuing further insurance recoveries. We do not believe that any other such proceedings, individually or in the aggregate, will have a material positive or adverse effect on the Company's consolidated financial position, results of operations or cash flows. However, legal proceedings and regulatory and governmental matters are subject to inherent uncertainties, and unfavorable rulings or other events could occur. Unfavorable resolutions could involve substantial fines, civil or criminal penalties, and other expenditures.

We believe our balance sheet is positioned to support the potential future challenges presented by the macro-economic pressures we are facing. As of the ~~second~~third quarter of fiscal 2023, cash and cash equivalents and restricted cash were ~~$270~~$254 million, while debt, finance lease ~~obligations~~ and other financing obligations were ~~$483~~$492 million. Borrowings under our credit facility as of ~~April~~July 1, 2023 were ~~$284~~$297 million, leaving ~~$216~~$203 million of our revolving commitment of $500 million available for use as well as the

Table of Contents

ability to expand our revolving commitment to $750 million upon mutual agreement with ~~the bank.~~our banks. Interest expense could increase above current levels due to increased borrowing under our credit facility associated with working capital investments along with the impact of rising interest rates. Refer to Note 3, "Debt, Finance Lease and Other Financing Obligations," in Notes to Condensed Consolidated Financial Statements and "Management’s Discussion and Analysis Liquidity and Capital Resources" in Part I, Item 2 for further information.

2022

Table of Contents

RESULTS OF OPERATIONS

Consolidated Performance Summary. The following table presents selected consolidated financial data (dollars in millions, except per share data):


		Three Months Ended						Six Months Ended							Three Months Ended						Nine Months Ended
		April 1, 2023			April 2, 2022			April 1, 2023			April 2, 2022				July 1, 2023			July 2, 2022			July 1, 2023			July 2, 2022
Net sales	Net sales	$	1,070.8		$	888.7		$	2,164.7		$	1,706.2		Net sales	$	1,021.6		$	981.3		$	3,186.4		$	2,687.5
Cost of sales	Cost of sales	967.8			812.2			1,960.6			1,559.7			Cost of sales	928.0			887.7			2,888.5			2,447.4
Gross profit	Gross profit	103.0			76.5			204.2			146.5			Gross profit	93.6			93.6			297.8			240.1
Gross margin	Gross margin	9.6		%	8.6		%	9.4		%	8.6		%	Gross margin	9.2		%	9.5		%	9.3		%	8.9		%
Operating income	Operating income	56.9			35.8			114.3			66.3			Operating income	28.2			49.6			142.5			115.9
Operating margin	Operating margin	5.3		%	4.0		%	5.3		%	3.9		%	Operating margin	2.8		%	5.1		%	4.5		%	4.3		%
Other expense	Other expense	9.1			4.5			17.0			8.2			Other expense	10.8			6.3			27.9			14.5
Income tax expense	Income tax expense	7.0			4.4			14.2			7.8			Income tax expense	1.6			5.8			15.8			13.6
Net income	Net income	40.8			26.9			83.0			50.3			Net income	15.8			37.5			98.8			87.8
Diluted earnings per share	Diluted earnings per share	$	1.45		$	0.95		$	2.94		$	1.76		Diluted earnings per share	$	0.56		$	1.33		$	3.51		$	3.09
Return on invested capital*	Return on invested capital*							13.8		%	10.2		%	Return on invested capital*							13.5		%	11.5		%
Economic return*	Economic return*							4.8		%	0.9		%	Economic return*							4.5		%	2.2		%
*Non-GAAP metric; refer to "Return on Invested Capital ("ROIC") and economic return" below and Exhibit 99.1 for more information.	*Non-GAAP metric; refer to "Return on Invested Capital ("ROIC") and economic return" below and Exhibit 99.1 for more information.													*Non-GAAP metric; refer to "Return on Invested Capital ("ROIC") and economic return" below and Exhibit 99.1 for more information.

Net sales. For the three months ended ~~April~~July 1, 2023, net sales increased ~~$182.1~~$40.3 million, or ~~20.5%~~4.1%, as compared to the three months ended ~~April~~July 2, 2022. For the ~~six~~nine months ended ~~April~~July 1, 2023, net sales increased ~~$458.5~~$498.9 million, or ~~26.9%~~18.6%, as compared to the ~~six~~nine months ended ~~April~~July 2, 2022.

Net sales are analyzed by management by geographic segment, which reflects our reportable segments, and by market sector. Management measures operational performance and allocates resources on a geographic segment basis. Our global business development strategy is based on our targeted market sectors.

A discussion of net sales by reportable segment is presented below (in millions):


		Three Months Ended				Six Months Ended					Three Months Ended				Nine Months Ended
		April 1, 2023		April 2, 2022		April 1, 2023		April 2, 2022			July 1, 2023		July 2, 2022		July 1, 2023		July 2, 2022
Net sales:	Net sales:									Net sales:
AMER	AMER	$	407.8	$	311.2	$	797.5	$	588.5	AMER	$	371.4	$	342.6	$	1,168.8	$	931.1
APAC	APAC	587.3		533.9		1,229.2		1,025.6		APAC	572.1		586.3		1,801.3		1,611.9
EMEA	EMEA	101.8		73.7		191.2		146.6		EMEA	104.4		84.2		295.6		230.7
Elimination of inter-segment sales	Elimination of inter-segment sales	(26.1)		(30.1)		(53.2)		(54.5)		Elimination of inter-segment sales	(26.3)		(31.8)		(79.3)		(86.2)
Total net sales	Total net sales	$	1,070.8	$	888.7	$	2,164.7	$	1,706.2	Total net sales	$	1,021.6	$	981.3	$	3,186.4	$	2,687.5

AMER. Net sales for the three months ended ~~April~~July 1, 2023 in the AMER segment increased ~~$96.6~~$28.8 million, or ~~31.0%~~8.4%, as compared to the three months ended ~~April~~July 2, 2022. The increase in net sales was driven by a ~~$64.0~~$42.7 million increase in production ramps of new products for existing ~~customers and~~customers. The increase was partially offset by overall net ~~increased~~decreased customer end-market demand ~~inclusive of~~and a partial easing of supply chain constraints that had previously created limitations with meeting available customer demand. The increase was also driven by higher pricing associated with inflated component prices.$5.6 million decrease for end-of-life products.

During the ~~six~~nine months ended ~~April~~July 1, 2023, net sales in the AMER segment increased ~~$209.0~~$237.7 million, or ~~35.5%~~25.5%, as compared to the ~~six~~nine months ended ~~April~~July 2, 2022. The increase in net sales was driven by a ~~$137.8~~$176.8 million increase in production ramps of new products for existing customers and overall net increased customer end-market demand, inclusive of a partial easing of supply chain constraints. The increase was also driven by higher pricing associated with inflated component prices and a ~~$15.0~~$17.3 million increase in production ramps for new customers. The increase was partially offset by an $11.0 million decrease for end-of-life products and a $6.3 million decrease due to the discontinuation of a program with an existing customer.

APAC. Net sales for the three months ended ~~April~~July 1, 2023 in the APAC segment ~~increased $53.4~~decreased $14.2 million, or ~~10.0%~~2.4%, as compared to the three months ended ~~April~~July 2, 2022. The decrease in net sales was driven by overall net decreased customer end-market

Table of Contents

demand, primarily as a result of the Department of Commerce's export control restrictions on the People's Republic of China. The decrease was partially offset by a $15.0 million increase in production ramps of new products for existing customers and a partial easing of supply chain constraints.

During the nine months ended July 1, 2023, net sales in the APAC segment increased $189.4 million, or 11.8%, as compared to the nine months ended July 2, 2022. The increase in net sales was driven by a partial easing of supply chain constraints, a $63.9 million increase in production ramps of new products for existing customers, higher pricing associated with inflated component prices and a $5.9 million increase in production ramps for a new customer. The increase was partially offset by overall net decreased customer end-market demand, primarily as a result of the Department of Commerce's export control restrictions on the People's Republic of China.

EMEA. Net sales for the three months ended July 1, 2023 in the EMEA segment increased $20.2 million, or 24.0%, as compared to the three months ended July 2, 2022. The increase in net sales was driven by overall net increased customer ~~end-~~end-market demand.

~~Table of Contents~~

market demand inclusive of a partial easing of supply chain constraints. The increase was also driven by higher pricing associated with inflated component prices and a $5.7 million increase in production ramps of new products for existing customers.

During the ~~six~~nine months ended ~~April~~July 1, 2023, net sales in the ~~APAC~~EMEA segment increased ~~$203.6~~$64.9 million, or ~~19.9%~~28.1%, as compared to the ~~six~~nine months ended ~~April~~July 2, 2022. The increase in net sales was driven by overall net increased customer end-market demand inclusive of a partial easing of supply chain ~~constraints. The increase was also driven by higher pricing associated with inflated component prices and a $18.8~~constraints, an $8.7 million increase in production ramps of new products for existing ~~customers.~~

~~EMEA.~~ ~~Net sales for the three months ended April 1, 2023 in the EMEA segment increased $28.1~~customers and a $5.0 million ~~or 38.1%, as compared to the three months ended April 2, 2022. The~~ increase in ~~net sales was driven by overall net increased customer end-market demand inclusive of~~production ramps for a ~~partial easing of supply chain constraints.~~

During the six months ended April 1, 2023, net sales in the EMEA segment increased $44.6 million, or 30.4%, as compared to the six months ended April 2, 2022. The increase in net sales was driven by overall net increased customer end-market demand inclusive of a partial easing of supply chain constraints.new customer.

Our net sales by market sector were as follows (in millions):


		Three Months Ended				Six Months Ended					Three Months Ended				Nine Months Ended
		April 1, 2023		April 2, 2022		April 1, 2023		April 2, 2022			July 1, 2023		July 2, 2022		July 1, 2023		July 2, 2022
Net sales:	Net sales:									Net sales:
Industrial	Industrial	$	439.3	$	414.7	$	911.4	$	778.5	Industrial	$	427.7	$	454.4	$	1,339.1	$	1,232.9
Healthcare/Life Sciences	Healthcare/Life Sciences	487.3		353.2		975.2		697.7		Healthcare/Life Sciences	451.0		400.8		1,426.2		1,098.5
Aerospace/Defense	Aerospace/Defense	144.2		120.8		278.1		230.0		Aerospace/Defense	142.9		126.1		421.1		356.1
Total net sales	Total net sales	$	1,070.8	$	888.7	$	2,164.7	$	1,706.2	Total net sales	$	1,021.6	$	981.3	$	3,186.4	$	2,687.5

Industrial. Net sales for the three months ended ~~April~~July 1, 2023 in the Industrial sector ~~increased $24.6~~decreased $26.7 million, or 5.9%, as compared to the three months ended ~~April~~July 2, 2022. The decrease in net sales was driven by overall net decreased customer end-market demand, primarily as a result of the Department of Commerce's export control restrictions on the People's Republic of China. The decrease was also driven by a $5.6 million decrease for end-of-life products. The overall decrease was partially offset by a $6.5 million increase in production ramps of new products for an existing customer.

During the nine months ended July 1, 2023, net sales in the Industrial sector increased $106.2 million, or 8.6%, as compared to the nine months ended July 2, 2022. The increase in net sales was driven by a ~~$10.7~~partial easing of supply chain constraints, a $67.2 million increase due to production ramps of new products for existing customers ~~a partial easing of supply chain constraints~~ and an $18.7 million increase in production ramps for new customers. The increase was also driven by higher pricing associated with inflated component prices. The increase was partially offset by overall net decreased customer end-market ~~demand.~~

~~During~~demand, primarily as a result of the ~~six months ended April 1, 2023, net sales in~~Department of Commerce's export control restrictions on the ~~Industrial sector increased $132.9~~People's Republic of China, as well as a $7.8 million or 17.1%, as compared to the six months ended April 2, 2022. The increase in net sales was driven by overall net increased customer end-market demand inclusive of a partial easing of supply chain constraints. The increase was also driven by higher pricing associated with inflated component prices, a $9.4 million increase in production rampsdecrease for ~~new customers and a $23.2 million increase due to production ramps of new products for existing customers.~~end-of-life products.

Healthcare/Life Sciences. Net sales for the three months ended ~~April~~July 1, 2023 in the Healthcare/Life Sciences sector increased ~~$134.1~~$50.2 million, or ~~38.0%~~12.5%, as compared to the three months ended ~~April~~July 2, 2022. The increase in net sales was driven by ~~overall net increased customer end-market demand inclusive of~~ a ~~partial easing of supply chain constraints. The increase was also driven by higher pricing associated with inflated component prices and a $66.8~~$48.1 million increase due to production ramps of new products for existing ~~customers.~~customers and a partial easing of supply chain constraints. The increase was partially offset by overall net decreased customer end-market demand.

During the ~~six~~nine months ended ~~April~~July 1, 2023, net sales in the Healthcare/Life Sciences sector increased ~~$277.5~~$327.7 million, or ~~39.8%~~29.8%, as compared to the ~~six~~nine months ended ~~April~~July 2, 2022. The increase in net sales was driven by a ~~$126.9~~$178.5 million increase due to production ramps of new products for existing customers and overall net increased customer end-market demand, inclusive of a partial easing of supply chain constraints. The increase was also driven by higher pricing associated with inflated component prices.

Aerospace/Defense. Net sales for the three months ended ~~April~~July 1, 2023 in the Aerospace/Defense sector increased ~~$23.4~~$16.8 million, or ~~19.4%~~13.3%, as compared to the three months ended ~~April~~July 2, 2022. The increase was driven by overall net increased customer end-market demand.

Table of Contents

During the nine months ended July 1, 2023, net sales in the Aerospace/Defense sector increased $65.0 million, or 18.3%, as compared to the nine months ended July 2, 2022. The increase was driven by overall net increased customer end-market demand, ~~and increased pricing associated with inflated component prices.~~

During the six months ended April 1, 2023, net sales in the Aerospace/Defense sector increased $48.1 million, or 20.9%, as compared to the six months ended April 2, 2022. The increase was driven by overall net increased customer end-market demand and increased pricing associated with inflated component prices ~~a $10.6 million increase due to production ramps of new products for existing customers~~ and a ~~$9.2~~$9.6 million increase in production ramps for a new customer.

~~Table~~ The increase was partially offset by a $6.0 million decrease due to the discontinuation of ~~Contents~~

a program with an existing customer.

Cost of sales. Cost of sales for the three months ended ~~April~~July 1, 2023 increased ~~$155.6~~$40.3 million, or ~~19.2%~~4.5%, as compared to the three months ended ~~April~~July 2, 2022, while cost of sales for the ~~six~~nine months ended ~~April~~July 1, 2023 increased ~~$400.9~~$441.1 million, or ~~25.7%~~18.0%, as compared to the ~~six~~nine months ended ~~April~~July 2, 2022. Cost of sales is comprised primarily of material and component costs, labor costs and overhead. For the three and ~~six~~nine months ended ~~April~~July 1, 2023 and ~~April~~July 2, 2022, approximately 89% to 90% of the total cost of sales was variable in nature and fluctuated with sales volumes. Of these amounts, approximately 87% to 88% of the variable costs for the three and ~~six~~nine months ended ~~April~~July 1, 2023 and ~~April~~July 2, 2022, were related to material and component costs.

As compared to the three months ended ~~April~~July 2, 2022, the increase in cost of sales for the three months ended ~~April~~July 1, 2023 was primarily driven by the increase in net sales, an increase in fixed costs and increased labor costs, partially offset by a positive shift in customer mix. As compared to the nine months ended July 2, 2022, the increase in cost of sales for the nine months ended July 1, 2023 was primarily driven by the increase in net sales, inflated component costs, an increase in fixed costs, ~~and~~increased labor costs and a negative shift in customer mix, partially offset by ~~a positive shift~~improvements in ~~customer mix. As~~operational efficiencies.

Gross profit. Gross profit for the three months ended July 1, 2023 remained flat, as compared to the ~~six~~three months ended ~~April~~July 2, ~~2022, the increase in cost~~2022. Gross margin of ~~sales~~9.2% for the ~~six~~three months ended ~~April~~July 1, 2023 ~~was primarily driven by~~decreased 30 basis points compared to the ~~increase~~three months ended July 2, 2022. The primary drivers of the decrease in ~~net sales, inflated component costs, an~~gross margin for the three months ended July 1, 2023 were the increase in fixed costs and increased labor costs, partially offset by a positive shift in customer ~~mix and improvements in operational efficiencies.~~mix.

~~Gross profit.~~Gross profit for the ~~three~~nine months ended ~~April~~July 1, 2023 increased ~~$26.5~~$57.7 million, or ~~34.6%~~24.0%, as compared to the ~~three~~nine months ended ~~April~~July 2, 2022. Gross margin of ~~9.6%~~9.3% for the ~~three~~nine months ended ~~April~~July 1, 2023 increased ~~100~~40 basis points compared to the ~~three~~nine months ended ~~April~~July 2, 2022. The primary drivers of the increase in gross profit and gross margin for the ~~three~~nine months ended ~~April~~July 1, 2023 were the increase in net sales ~~and positive shift in customer mix, partially offset by inflated component costs as well as an increase in fixed costs and labor costs.~~

Gross profit for the six months ended April 1, 2023 increased $57.7 million, or 39.4%, as compared to the six months ended April 2, 2022. Gross margin of 9.4% for the six months ended April 1, 2023 increased 80 basis points compared to the six months ended April 2, 2022. The primary drivers of the increase in gross profit and gross margin for the six months ended April 1, 2023 were the increase in net sales, a positive shift in customer mix and improvements in operational efficiencies, partially offset by inflated component costs, an increase in fixed costs, increased labor costs and ~~an increase~~a negative shift in ~~labor costs.~~customer mix.

Operating income. Operating income for the three months ended ~~April~~July 1, 2023 ~~increased $21.1~~decreased $21.4 million, or ~~58.9%~~43.1%, as compared to the three months ended ~~April~~July 2, 2022. Operating margin of ~~5.3%~~2.8% for the three months ended ~~April~~July 1, 2023 ~~increased 130~~decreased 230 basis points compared to the three months ended ~~April~~July 2, 2022. The primary driver of the decrease in operating income and operating margin for the three months ended July 1, 2023 was the result of a $23.1 million increase in restructuring and other charges along with the decrease in gross margin, partially offset by a $1.7 million decrease in selling and administrative expenses ("S&A"). The decrease in S&A was primarily due to a decrease in incentive compensation costs.

Operating income for the nine months ended July 1, 2023 increased $26.6 million, or 23.0%, as compared to the nine months ended July 2, 2022. Operating margin of 4.5% for the nine months ended July 1, 2023 increased 20 basis points compared to the nine months ended July 2, 2022. The primary driver of the increase in operating income and operating margin for the ~~three~~nine months ended ~~April~~July 1, 2023 was the result of the increase in gross profit and gross margin, partially offset by a ~~$5.4~~$21.1 million increase in ~~selling and administrative expenses ("S&A"). The increase in S&A was primarily due to an increase in compensation costs.~~

Operating income for the six months ended April 1, 2023 increased $48.0 million, or 72.4%, as compared to the six months ended April 2, 2022. Operating margin of 5.3% for the six months ended April 1, 2023 increased 140 basis points compared to the six months ended April 2, 2022. The primary driver of the increase in operating income and operating margin for the six months ended April 1, 2023 was the result of the increase in gross profit and gross margin along with a $2.0 million decrease in restructuring and ~~impairment~~other charges ~~partially offset by an $11.7~~and a $10.0 million increase in S&A. The increase in S&A was primarily due to ana net increase in compensation costs.

A discussion of operating income by reportable segment presented below (in millions):


		Three Months Ended				Six Months Ended					Three Months Ended				Nine Months Ended
		April 1, 2023		April 2, 2022		April 1, 2023		April 2, 2022			July 1, 2023		July 2, 2022		July 1, 2023		July 2, 2022
Operating income:	Operating income:									Operating income:
AMER	AMER	$	25.8	$	7.8	$	43.2	$	9.6	AMER	$	15.9	$	17.0	$	59.1	$	26.5
APAC	APAC	69.7		60.8		148.1		121.5		APAC	69.9		67.3		218.0		188.8
EMEA	EMEA	1.8		0.4		1.2		1.4		EMEA	0.8		2.6		2.0		4.0
Corporate and other costs	Corporate and other costs	(40.4)		(33.2)		(78.2)		(66.2)		Corporate and other costs	(58.4)		(37.3)		(136.6)		(103.4)
Total operating income	Total operating income	$	56.9	$	35.8	$	114.3	$	66.3	Total operating income	$	28.2	$	49.6	$	142.5	$	115.9

AMER. Operating income ~~increased $18.0~~decreased $1.1 million for the three months ended ~~April~~July 1, 2023 as compared to the three months ended ~~April~~July 2, 2022, primarily as a result of increased fixed costs and increased labor costs, partially offset by an increase in net sales.

Table of Contents

During the nine months ended July 1, 2023, operating income in the AMER segment increased $32.6 million as compared to the nine months ended July 2, 2022, primarily as a result of an increase in net sales and improvements in operational efficiencies, ~~and~~partially offset by a ~~positive~~negative shift in customer mix, ~~partially offset by inflated component~~increased fixed costs, ~~and an increase in S&A.~~

~~Table of Contents~~

~~During the six months ended April 1, 2023, operating income in the AMER segment~~ increased $33.6 million as compared to the six months ended April 2, 2022, primarily as a result of an increase in net sales, improvements in operational efficiencies and a positive shift in customer mix, partially offset bylabor costs, inflated component costs and an increase in S&A.

APAC. Operating income increased ~~$8.9~~$2.6 million for the three months ended ~~April~~July 1, 2023 as compared to the three months ended ~~April~~July 2, 2022, primarily as a result of a positive shift in customer mix, partially offset by a decrease in net sales, increased fixed costs and increased labor costs.

During the nine months ended July 1, 2023, operating income in the APAC segment increased $29.2 million as compared to the nine months ended July 2, 2022, primarily as a result of an increase in net sales and a positive shift in customer mix, partially offset by ~~inflated component costs,~~ increased fixed costs, ~~and~~reduced operational efficiencies, increased labor ~~costs.~~

During the six months ended April 1, 2023, operating income in the APAC segment increased $26.6 million as compared to the six months ended April 2, 2022, primarily as a result of an increase in net sales, a positive shift in customer mix and improvements in operational efficiencies, partially offset bycosts, inflated component ~~costs, an increase in fixed costs, increased labor~~ costs and an increase in S&A.

EMEA. Operating income ~~increased $1.4~~decreased $1.8 million for the three months ended ~~April~~July 1, 2023 as compared to the three months ended ~~April~~July 2, 2022, primarily as a result of increased fixed costs and increased labor costs, partially offset by an increase in net ~~sales and improvements in operational efficiencies, partially offset by inflated component costs, a negative shift in customer mix and increased fixed costs.~~sales.

During the ~~six~~nine months ended ~~April~~July 1, 2023, operating income in the EMEA segment decreased ~~$0.2~~$2.0 million as compared to the ~~six~~nine months ended ~~April~~July 2, 2022, primarily as a result of ~~inflated component costs,~~a negative shift in customer mix, increased fixed costs and ~~an increase in S&A,~~increased labor costs, partially offset by an increase in net ~~sales and improvements in operational efficiencies.~~sales.

Other expense. Other expense for the three months ended ~~April~~July 1, 2023 increased ~~$4.6~~$4.5 million as compared to the three months ended ~~April~~July 2, 2022. The increase in other expense for the three months ended ~~April~~July 1, 2023 was primarily due to the increase in interest expense of ~~$4.9~~$4.3 million due to a higher average interest rate and the higher average daily borrowing levels.

Other expense for the nine months ended July 1, 2023 increased $13.4 million as compared to the nine months ended July 2, 2022. The increase in other expense was primarily driven by an increase in interest expense of $13.1 million due to a higher average interest rate and the higher average daily borrowing levels. The increase was also due to an increase in factoring fees of ~~$2.0~~$4.7 million, partially offset by ~~an increase of~~increases in other miscellaneous income of ~~$2.0 million.~~

~~Other expense for the six months ended April 1, 2023 increased $8.8~~$3.3 million ~~as compared to the six months ended April 2, 2022. The increase in other expense was primarily driven by an increase in~~and interest expense of $8.8 million due to a higher average interest rate and the higher average daily borrowing levels. The increase was also due to an increase in factoring fees of $3.5 million, partially offset by an increase of other miscellaneous income of ~~$2.9~~$1.4 million.

Income taxes. Income tax expense for the three and ~~six~~nine months ended ~~April~~July 1, 2023 was ~~$7.0~~$1.6 million and ~~$14.2~~$15.8 million, respectively, compared to ~~$4.4~~$5.8 million and ~~$7.8~~$13.6 million for the three and ~~six~~nine months ended ~~April~~July 2, 2022, respectively. The ~~increase is~~decrease for the three months ended July 1, 2023 as compared to July 2, 2022 was primarily due to an increase in discrete tax benefits of $3.0 million and a decrease in pre-tax book ~~income and~~income. The increase for the nine months ended July 1, 2023 as compared to July 2, 2022 was primarily due to a change in the geographic distribution of pre-tax book ~~income.~~income and an increase in pre-tax book income, partially offset by an increase in discrete tax benefits of $3.2 million.

Our annual effective tax rate varies from the U.S. statutory rate of 21.0% primarily due to the geographic distribution of worldwide earnings as well as a tax holiday granted to a subsidiary located in the APAC segment where we derive a significant portion of our earnings. Our effective tax rate may also be impacted by disputes with taxing authorities, tax planning activities, adjustments to uncertain tax positions and changes in valuation allowances.

The annual effective tax rate for fiscal 2023 is expected to be approximately ~~14.0%~~13.0% to ~~16.0%~~15.0% assuming no changes to tax laws.

Net ~~Income.~~income. Net income for the three months ended ~~April~~July 1, 2023 ~~increased $13.9~~decreased $21.7 million, or ~~51.7%~~57.9%, from the three months ended ~~April~~July 2, 2022 to ~~$40.8~~$15.8 million. Net income ~~increased~~decreased primarily as a result of the ~~increase~~decrease in operating income and an increase in other expense, partially offset by ~~an increase~~a decrease in tax ~~expense and other~~ expense, as previously discussed.

Net income for the ~~six~~nine months ended ~~April~~July 1, 2023 increased ~~$32.7~~$11.0 million, or ~~65.0%~~12.5%, from the ~~six~~nine months ended ~~April~~July 2, 2022 to ~~$83.0~~$98.8 million. Net income increased primarily as a result of the increase in operating income, partially offset by an increase in tax expense and other expense, as previously discussed.

Diluted earnings per share. Diluted earnings per share ~~increased~~decreased to ~~$1.45~~$0.56 for the three months ended ~~April~~July 1, 2023 from ~~$0.95~~$1.33 for the three months ended ~~April~~July 2, 2022, primarily as a result of ~~increased~~decreased net income due to the factors previously discussed, ~~as well as~~partially offset by a reduction in diluted shares outstanding due to repurchase activity under our share repurchase plans.

Diluted earnings per share increased to ~~$2.94~~$3.51 for the ~~six~~nine months ended ~~April~~July 1, 2023 from ~~$1.76~~$3.09 for the ~~six~~nine months ended ~~April~~July 2, 2022 primarily as a result of increased net income due to the factors previously discussed as well as a reduction in diluted shares outstanding due to repurchase activity under our share repurchase plans.

2426

Table of Contents

Return on Invested Capital ("ROIC") and economic return. We use a financial model that is aligned with our business strategy and includes an ROIC goal of 15% which would exceed our weighted average cost of capital ("WACC") by more than 500 basis points and represent positive economic return. Economic return is the amount our ROIC exceeds our WACC.

Non-GAAP financial measures, including ROIC and economic return, are used for internal management goals and decision making because such measures provide management and investors additional insight into financial performance. In particular, we provide ROIC and economic return because we believe they offer insight into the metrics that are driving management decisions. We view ROIC and economic return as important measures in evaluating the efficiency and effectiveness of our long-term capital investments. We also use ROIC as a performance criteria in determining certain elements of compensation as well as economic return performance.

We define ROIC as tax-effected operating income before restructuring and other special items divided by average invested capital over a rolling ~~three-quarter~~four-quarter period for the ~~second~~third quarter. Invested capital is defined as equity plus debt and operating lease liabilities, less cash and cash equivalents. Other companies may not define or calculate ROIC in the same way. ROIC and other non-GAAP financial measures should be considered in addition to, not as a substitute for, measures of our financial performance prepared in accordance with U.S. generally accepted accounting principles ("U.S. GAAP").

We review our internal calculation of WACC annually. Our WACC is 9.0% for fiscal 2023 as compared to 9.3% for fiscal 2022. By exercising discipline to generate ROIC in excess of our WACC, our goal is to create value for our shareholders. For the ~~six~~nine months ended ~~April~~July 1, 2023, ROIC of ~~13.8%~~13.5% reflects an economic return of ~~4.8%~~4.5%, based on our weighted average cost of capital of 9.0%. For the ~~six~~nine months ended ~~April~~July 2, 2022, ROIC of ~~10.2%~~11.5% reflects an economic return of ~~0.9%~~2.2%, based on our weighted average cost of capital of 9.3% for that fiscal year.

For a reconciliation of ROIC, economic return and adjusted operating income (tax-effected) to our financial statements that were prepared using U.S. GAAP, see Exhibit 99.1 to this quarterly report on Form 10-Q, which exhibit is incorporated herein by reference.

Refer to the table below, which includes the calculation of ROIC and economic return for the indicated fiscal period (dollars in millions):


		Six Months Ended							Nine Months Ended
		April 1, 2023			April 2, 2022				July 1, 2023			July 2, 2022
Adjusted operating income (tax-effected)	Adjusted operating income (tax-effected)	$	194.3		$	117.5		Adjusted operating income (tax-effected)	$	192.1		$	135.2
Average invested capital	Average invested capital	1,406.4			1,151.8			Average invested capital	1,423.0			1,178.1
After-tax ROIC	After-tax ROIC	13.8		%	10.2		%	After-tax ROIC	13.5		%	11.5		%
WACC	WACC	9.0		%	9.3		%	WACC	9.0		%	9.3		%
Economic return	Economic return	4.8		%	0.9		%	Economic return	4.5		%	2.2		%

2527

Table of Contents

LIQUIDITY AND CAPITAL RESOURCES

Cash and cash equivalents and restricted cash were ~~$270.4~~$253.6 million as of ~~April~~July 1, 2023, as compared to $275.5 million as of October 1, 2022.

As of ~~April~~July 1, 2023, ~~86%~~92% of our cash and cash equivalents balance was held outside of the U.S. by our foreign subsidiaries. Currently, we believe that our cash balance, together with cash available under our Credit Facility, will be sufficient to meet our liquidity needs and be sufficient to cover potential share repurchases, if any, for the next twelve months and for the foreseeable future.

Our future cash flows from operating activities will be reduced by $42.0 million due to cash payments for U.S. federal taxes on the deemed repatriation of undistributed foreign earnings that are payable over an eight-year period that began in fiscal 2019 with the first payment. The table below provides the expected timing of these future cash outflows, in accordance with the following installment schedule for the remaining three years (in millions):


2024	$	10.6
2025	14.1
2026	17.3
Total	$	42.0

Cash Flows. The following table provides a summary of cash flows (in millions):


		Six Months Ended					Nine Months Ended
		April 1, 2023		April 2, 2022			July 1, 2023		July 2, 2022
Cash provided by (used in) operating activities	Cash provided by (used in) operating activities	$	57.2	$	(4.7)	Cash provided by (used in) operating activities	$	76.0	$	(25.8)
Cash used in investing activities	Cash used in investing activities	(47.6)		(64.3)		Cash used in investing activities	(77.7)		(85.1)
Cash (used in) provided by financing activities	Cash (used in) provided by financing activities	(18.4)		107.8		Cash (used in) provided by financing activities	(22.4)		122.1

Operating Activities. Cash flows provided by operating activities were ~~$57.2~~$76.0 million for the ~~six~~nine months ended ~~April~~July 1, 2023, as compared to cash flows used in operating activities of ~~$4.7~~$25.8 million for the ~~six~~nine months ended ~~April~~July 2, 2022. The change was primarily due to cash flow improvements (reductions) of:

•$~~32.7~~11.0 million increase in net income.

•$~~371.7~~576.2 million in inventory cash flows driven by inventory levels increasing at a slower rate in the ~~six~~nine months ended ~~April~~July 1, 2023 as compared to the ~~six~~nine months ended ~~April~~July 2, 2022. In the ~~six~~nine months ended ~~April~~July 1, 2023, inventory levels have primarily increased to support the ramp of customer programs, as well as supply chain constraints have led to inflation in some of the components we acquire, increasing inventory.

•$~~138.5~~139.8 million in accounts receivable cash flows driven by timing of shipments and mix of customer payment ~~terms and increased factoring of receivables.~~terms.

•$~~7.6 million in other current and non-current assets driven by a lesser increase in prepayments to suppliers as compared to the six months ended April 2, 2022.~~

•~~$6.3~~18.9 million in contract assets cash flows driven by increases in advance payments received from customers who recognize revenue over time.

•$~~(224.4)~~12.3 million in other current and non-current assets driven by a lesser increase in prepayments to suppliers as compared to the nine months ended July 2, 2022.

•$(344.1) million in accounts payables cash ~~flows~~outflows primarily driven by the timing of materials procurement and payments to suppliers.

•$~~(157.3)~~(214.4) million in other current and non-current liabilities cash ~~flows~~outflows driven by releases of advance payments to customers as we sold products that contained inflated component ~~prices.~~prices in the nine months ended July 1, 2023 compared to an increase in advanced payments from customers in the nine months ended July 2, 2022.

•$~~(113.2)~~(91.8) million in customer deposit cash ~~flows~~outflows driven by deposits increasing at a slower rate in the ~~six~~nine months ended ~~April~~July 1, 2023 as compared to the ~~six~~nine months ended ~~April~~July 2, 2022, consistent with inventory cash flows. Deposit increases in both periods were primarily to cover certain inventory balances.

2628

Table of Contents

The following table provides a summary of cash cycle days for the periods indicated (in days):


		Three Months Ended			Three Months Ended
		April 1, 2023	April 2, 2022		July 1, 2023	July 2, 2022
Days in accounts receivable	Days in accounts receivable	56	59	Days in accounts receivable	63	57
Days in contract assets	Days in contract assets	11	12	Days in contract assets	12	12
Days in inventory	Days in inventory	156	154	Days in inventory	161	160
Days in accounts payable	Days in accounts payable	(69)	(86)	Days in accounts payable	(68)	(87)
Days in cash deposits	Days in cash deposits	(50)	(41)	Days in cash deposits	(57)	(40)
Annualized cash cycle	Annualized cash cycle	104	98	Annualized cash cycle	111	102

We calculate days in accounts receivable and contract assets as each balance sheet item for the respective quarter divided by annualized sales for the respective quarter by day. We calculate days in inventory, accounts payable and cash deposits as each balance sheet line item for the respective quarter divided by annualized cost of sales for the respective quarter by day. We calculate annualized cash cycle as the sum of days in accounts receivable, days in contract assets and days in inventory, less days in accounts payable and days in cash deposits.

As of ~~April~~July 1, 2023, annualized cash cycle days increased ~~six~~nine days compared to ~~April~~July 2, 2022 due to the following:

Days in accounts receivable for the three months ended ~~April~~July 1, 2023 ~~decreased three~~increased six days compared to the three months ended ~~April~~July 2, 2022. The ~~decrease~~increase is primarily attributable to ~~an increase in factored receivables.~~mix of customer payment terms and the timing of customer shipments and payments.

Days in contract assets for the three months ended ~~April~~July 1, 2023 ~~decreased one day~~remained flat compared to the three months ended ~~April~~July 2, 2022. ~~The decrease is primarily attributable to an increase in advance payments received from customers with arrangements requiring revenue to be recognized over time as products are produced.~~

Days in inventory for the three months ended ~~April~~July 1, 2023 increased ~~two days~~one day compared to the three months ended ~~April~~July 2, 2022. The increase is primarily attributable to increased inventory levels to support the ramp of customer programs. ~~Inventory levels also increased due to customer demand volatility as well as supply chain constraints which have led to inflation in some of the components we acquire.~~

Days in accounts payable for the three months ended ~~April~~July 1, 2023 decreased ~~seventeen~~nineteen days compared to the three months ended ~~April~~July 2, 2022. The decrease is primarily attributable to timing of materials procurement and payments to suppliers.

Days in cash deposits for the three months ended ~~April~~July 1, 2023 increased ~~nine~~seventeen days compared to the three months ended ~~April~~July 2, 2022. The increase was primarily attributable to significant deposits received from customers to cover certain increasing inventory balances.

Free Cash Flow. We define free cash flow ("FCF"), a non-GAAP financial measure, as cash flow ~~used in~~provided by (used in) operations less capital expenditures. FCF was ~~$7.7~~$(3.8) million for the ~~six~~nine months ended ~~April~~July 1, 2023 compared to ~~$(68.8)~~$(110.8) million for the ~~six~~nine months ended ~~April~~July 2, 2022, an improvement of ~~$76.5~~$107.0 million. The improvement in FCF was primarily due to lower working capital investments in inventory to support our customers in the ~~six~~nine months ended ~~April~~July 1, 2023 as compared to the ~~six~~nine months ended ~~April~~July 2, 2022.

Non-GAAP financial measures, including FCF, are used for internal management assessments because such measures provide additional insight to investors into ongoing financial performance. In particular, we provide FCF because we believe it offers insight into the metrics that are driving management decisions. We view FCF as an important financial metric as it demonstrates our ability to generate cash and can allow us to pursue opportunities that enhance shareholder value. FCF is a non-GAAP financial measure that should be considered in addition to, not as a substitute for, measures of our financial performance prepared in accordance with U.S. GAAP.

2729

Table of Contents

A reconciliation of FCF to our financial statements that were prepared using U.S. GAAP as follows (in millions):


		Six Months Ended					Nine Months Ended
		April 1, 2023		April 2, 2022			July 1, 2023		July 2, 2022
Cash flows provided by (used in) operating activities	Cash flows provided by (used in) operating activities	$	57.2	$	(4.7)	Cash flows provided by (used in) operating activities	$	76.0	$	(25.8)
Payments for property, plant and equipment	Payments for property, plant and equipment	(49.5)		(64.1)		Payments for property, plant and equipment	(79.8)		(85.0)
Free cash flow	Free cash flow	$	7.7	$	(68.8)	Free cash flow	$	(3.8)	$	(110.8)

Investing Activities. Cash flows used in investing activities were ~~$47.6~~$77.7 million for the ~~six~~nine months ended ~~April~~July 1, 2023 compared to ~~$64.3~~$85.1 million for the ~~six~~nine months ended ~~April~~July 2, 2022. The decrease in cash used in investing activities was due to a ~~$14.7~~$5.2 million decrease in capital expenditures, as the manufacturing footprint expansion in Bangkok, Thailand has been substantially completed.

We estimate capital expenditures for fiscal 2023 will be approximately ~~$110.0~~$115.0 million to ~~$130.0~~$125.0 million to support new program ramps and replace older equipment. ~~This estimate does not contemplate any site expansions.~~

Financing Activities. Cash flows used in financing activities were ~~$18.4~~$22.4 million for the ~~six~~nine months ended ~~April~~July 1, 2023 compared to cash flows provided by financing activities of ~~$107.8~~$122.1 million for the ~~six~~nine months ended ~~April~~July 2, 2022. The decrease was primarily attributable to ~~lower~~a lesser increase in borrowings on the credit facility in the ~~six~~nine months ended ~~April~~July 1, 2023 of ~~$21.0~~$34.0 million as compared to the ~~six~~nine months ended ~~April~~July 2, 2022 of ~~$157.0~~$185.0 million and a decrease of ~~$11.3~~$9.5 million in cash used to repurchase our common stock.

On August 11, 2021, the Board of Directors approved a share repurchase program under which we were authorized to repurchase up to $50.0 million of our common stock (the "2022 Program"). The 2022 Program commenced upon completion of the 2021 Program and was completed in fiscal 2022. During the three months ended ~~April~~July 2, 2022, we repurchased ~~305,707~~148,571 shares under this program for ~~$25.0~~$11.7 million at an average price of ~~$81.79~~$79.27 per share. During the ~~six~~nine months ended ~~April~~July 2, 2022, we repurchased ~~416,147~~564,718 shares under this program for ~~$35.2~~$46.9 million at an average price of ~~$84.43~~$83.07 per share.

On August 18, 2022, the Board of Directors approved a share repurchase program under which we are authorized to repurchase up to $50.0 million of our common stock (the "2023 Program"). The 2023 Program became effective immediately and has no expiration. During the three months ended ~~April~~July 1, 2023, we repurchased ~~125,639~~149,783 shares under this program for ~~$12.4~~$13.5 million at an average price of ~~$98.75~~$90.49 per share. During the ~~six~~nine months ended ~~April~~July 1, 2023, we repurchased ~~241,362~~391,145 shares under this program for ~~$23.9~~$37.4 million at an average price of ~~$98.93~~$95.70 per share. As of ~~April~~July 1, 2023, ~~$22.6~~$9.1 million of the 2023 Program remained available to repurchase shares.

All shares repurchased under the aforementioned programs were recorded as treasury stock.

We have Master Accounts Receivable Purchase Agreements with MUFG Bank, New York Branch (formerly known as The Bank of Tokyo-Mitsubishi UFJ, Ltd.) (the "MUFG RPA"), HSBC Bank (China) Company Limited, Xiamen branch (the "HSBC RPA") and other unaffiliated financial institutions, under which we may elect to sell receivables, at a discount. These facilities are uncommitted facilities. The maximum facility amount under the MUFG RPA as of ~~April~~July 1, 2023 was $340.0 million. The maximum facility amount under the HSBC RPA as of ~~April~~July 1, 2023 was $60.0 million. The MUFG RPA will be automatically extended each year unless any party gives no less than 10 days prior notice that the agreement should not be extended. The terms of the HSBC RPA are generally consistent with the terms of the MUFG RPA previously discussed.

We sold ~~$225.7~~$205.3 million and ~~$202.2~~$213.6 million of trade accounts receivable under these programs, or their predecessors, during the three months ended ~~April~~July 1, 2023 and ~~April~~July 2, 2022, respectively, in exchange for cash proceeds of ~~$222.9~~$202.9 million and ~~$201.5~~$212.3 million, respectively. We sold ~~$411.3~~$616.6 million and ~~$350.2~~$563.8 million of trade accounts receivable under these programs, or their predecessors, during the ~~six~~nine months ended ~~April~~July 1, 2023 and ~~April~~July 2, 2022, respectively, in exchange for cash proceeds of ~~$406.5~~$609.4 million and ~~$349.0~~$561.3 million, respectively. As of ~~April~~July 1, 2023 and October 1, 2022, ~~$233.4~~$216.8 million and $222.5 million, respectively, of accounts receivables sold under trade accounts receivable programs and subject to servicing by us remained outstanding and had not yet been collected.

In all cases, the sale discount was recorded within "Miscellaneous, net" in the Condensed Consolidated Statements of Comprehensive Income in the period of the sale. For further information regarding the receivable sale programs, see Note 13, "Trade Accounts Receivable Sale Programs," in Notes to Condensed Consolidated Financial Statements.

Based on current expectations, we believe that our projected cash flows provided by operations, available cash and cash equivalents, our leasing capabilities and potential borrowings under our 5-year senior unsecured revolving credit facility

2830

Table of Contents

(referred to as the "Credit Facility"), including our ability to expand our revolving commitment, should be sufficient to meet our working capital and fixed capital requirements, as well as execution upon our share repurchase authorizations as management deems appropriate, for the next twelve ~~months.~~months and for the forseeable future. We believe our balance sheet is positioned to support the potential future challenges presented by macro-economic factors including increased working capital requirements associated with ~~longer lead-times for components, increased component and labor costs, and operating inefficiencies due to supply chain constraints.~~our sales growth. As of the end of the ~~second~~third quarter of fiscal 2023, cash and cash equivalents and restricted cash were ~~$270.4~~$253.6 million, while debt, finance lease ~~obligations~~ and other financing obligations were ~~$482.7~~$492.2 million. If our future financing needs increase, including to support additional capital expenditures or investments in the growth of our business, then we may need to arrange additional debt or equity financing. Accordingly, we evaluate and consider from time to time various financing alternatives to supplement our existing financial resources. However, we cannot be assured that we will be able to make any such arrangements on acceptable terms or at all.

2931

Table of Contents

DISCLOSURE ABOUT CRITICAL ACCOUNTING ESTIMATES

Our critical accounting policies are disclosed in our 2022 Annual Report on Form 10-K. During the ~~second~~third quarter of fiscal 2023, there were no material changes.

NEW ACCOUNTING PRONOUNCEMENTS

See Note 1, "Basis of Presentation," in Notes to Condensed Consolidated Financial Statements regarding recent accounting pronouncements.

ITEM 3. QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK

There were no material changes in our exposure to market risk from changes in foreign exchange and interest rates from those disclosed in our 2022 Annual Report on Form 10-K.

Foreign Currency Risk

Our international operations create potential foreign exchange risk. Our policy is to selectively hedge our foreign currency denominated transactions in a manner that partially offsets the effects of changes in foreign currency exchange rates. We typically use foreign currency contracts to hedge only those currency exposures associated with certain assets and liabilities denominated in non-functional currencies. Corresponding gains and losses on the underlying transaction generally offset the gains and losses on these foreign currency hedges. We cannot predict changes in currency rates, nor the degree to which we will be able to manage the impacts of currency exchange rate changes. Such changes could have a material effect on our business, results of operations and financial condition.

Our percentages of transactions denominated in currencies other than the U.S. dollar for the indicated periods were as follows:


		Three Months Ended			Three Months Ended
		April 1, 2023	April 2, 2022		July 1, 2023	July 2, 2022
Net Sales	Net Sales	9%	9%	Net Sales	9%	9%
Total Costs	Total Costs	21%	18%	Total Costs	16%	15%

We have evaluated the potential foreign currency exchange rate risk on transactions denominated in currencies other than the U.S. dollar for the periods presented above. Based on our overall currency exposure, as of ~~April~~July 1, 2023, a 10.0% change in the value of the U.S. dollar relative to our other transactional currencies would not have a material effect on our financial position, results of operations, or cash flows.

Interest Rate Risk

We have financial instruments, including cash equivalents and debt, which are sensitive to changes in interest rates. The primary objective of our investment activities is to preserve principal, while maximizing yields without significantly increasing market risk. To achieve this, we limit the amount of principal exposure to any one issuer.

As of ~~April~~July 1, 2023, our only material interest rate risk was associated with our Credit Facility. Borrowings under the Credit Facility bear interest, at the Company's option, at (a)(1) for borrowings denominated in U.S. dollars, the Term Secured Overnight Financing Rate ("SOFR"), (2) for borrowings denominated in pounds sterling, the Daily Simple Risk-Free Rate, plus, in each case of (a)(1) and (2), 10 basis points, (b) for borrowings denominated in euros, the EURIBOR Rate plus a statutory reserve rate, or (c) an Alternate Base Rate equal to the highest of (i) 100 basis points per annum, (ii) the prime rate last quoted by The Wall Street Journal (or, if not quoted, as otherwise provided in the Credit Facility), (iii) the greater of the federal funds effective rate and the overnight bank funding rate in effect on such day plus, in each case, 50 basis points per annum (or, if neither are available, as otherwise provided in the Credit Facility), and (iv) Term SOFR for a one month interest period on such day plus 110 basis points, plus, in each case of (a), (b), and (c), an applicable interest rate margin based on the Company's then current consolidated total indebtedness (minus certain unrestricted cash and cash equivalents in an amount not to exceed $100 million) to consolidated EBITDA. As of ~~April~~July 1, 2023, the borrowing rate under the Credit Facility was SOFR plus 1.10%. Borrowings under the 2018 Note Purchase Agreement are based on a fixed interest rate, thus mitigating much of our interest rate risk. Based on our overall interest rate exposure, as of ~~April~~July 1, 2023, a 10.0% change in interest rates would not have a material effect on our financial position, results of operations, or cash flows.

3032

Table of Contents

ITEM 4. CONTROLS AND PROCEDURES

Disclosure Controls and Procedures

The Company maintains disclosure controls and procedures designed to ensure that the information the Company must disclose in its filings with the Securities and Exchange Commission ("SEC") is recorded, processed, summarized and reported on a timely basis. The Company’s Chief Executive Officer ("CEO") and Chief Financial Officer ("CFO") have reviewed and evaluated, with the participation of the Company’s management, the Company’s disclosure controls and procedures as defined in Rules 13a-15(e) and 15d-15(e) under the Securities Exchange Act of 1934, as amended (the "Exchange Act") as of the end of the period covered by this report. Based on such evaluation, the CEO and CFO have concluded that, as of the Evaluation Date, the Company’s disclosure controls and procedures are effective, at the reasonable assurance level, (a) in recording, processing, summarizing and reporting, on a timely basis, information required to be disclosed by the Company in the reports the Company files or submits under the Exchange Act, and (b) in assuring that information is accumulated and communicated to the Company’s management, including the CEO and CFO, as appropriate to allow timely decisions regarding required disclosure.

Changes in Internal Control Over Financial Reporting

During the ~~second~~third quarter of fiscal 2023, there have been no changes in the Company’s internal control over financial reporting (as defined in Rules 13a-15(f) and 15d-15(f) under the Exchange Act) that have materially affected, or are reasonably likely to materially affect, the Company’s internal control over financial reporting.

PART II. OTHER INFORMATION

ITEM 1A. Risk Factors

In addition to the risks and uncertainties discussed herein, particularly those discussed in the “Safe Harbor” Cautionary Statement and "Management’s Discussion and Analysis of Financial Condition and Results of Operations" in Part I, Item 2, see the risk factors set forth in Part I, Item 1A of our Annual Report on Form 10-K for the fiscal year ended October 1, 2022 that have had no material changes.

ITEM 2. Unregistered Sales of Equity Securities and Use of Proceeds

The following table provides the specified information about the repurchases of shares by usthe Company during the three months ended ~~April~~July 1, 2023:

Period Total number of shares purchased Average price paid per share Total number of shares purchased as part of publicly announced plans or programs Maximum approximate dollar value of shares that may yet be purchased under the plans or programs (1)
January 1, 2023 -
January 28, 2023 21,085 $ 108.70 21,085 $ 32,757,884
January 29, 2023 -
February 25, 2023 46,332 97.78 46,332 28,227,520
February 26, 2023 -
April 1, 2023 58,222 95.92 58,222 22,642,676
125,639 $ 98.75 125,639


Period	Total number of shares purchased	Average price paid per share		Total number of shares purchased as part of publicly announced plans or programs	Maximum approximate dollar value of shares that may yet be purchased under the plans or programs (1)
April 2, 2023 - April 29, 2023	50,949	$	93.23	50,949	$	17,982,510
April 30, 2023 - May 27, 2023	65,394	86.67		65,394	12,225,099
May 28, 2023 - July 1, 2023	33,440	93.79		33,440	9,088,846
	149,783	$	90.49	149,783

(1) On August 18, 2022, the Board of Directors approved a new share repurchase program that authorizes the Company to repurchase up to $50.0 million of its common stock (the "2023 Program"). The 2023 Program became effective immediately and has no expiration. The table above reflects the maximum dollar amount remaining available for purchase under the 2023 Program as of ~~April~~July 1, 2023.

ITEM 5. Other Information

On May 11, 2023, Todd Kelsey, the Company's Chief Executive Officer, adopted a Rule 10b5-1 trading arrangement that is intended to satisfy the affirmative defense of Rule 10b5-1(c) for the sale of up to 45,656 shares of the Company's common stock through August 2024.

Table of Contents

ITEM 6. EXHIBITS

The list of exhibits is included below.



Exhibit No.						Exhibit
31.1						Certification of Chief Executive Officer pursuant to Section 302(a) of the Sarbanes-Oxley Act of 2002.
31.2						Certification of Chief Financial Officer pursuant to Section 302(a) of the Sarbanes-Oxley Act of 2002.
32.1						Certification of the CEO pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.
32.2						Certification of the CFO pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.
99.1						Reconciliation of ROIC to GAAP and Economic Return Financial Statements.
101						The following materials from Plexus Corp.’s Quarterly Report on Form 10-Q for the fiscal quarter ended ~~April~~July 1, 2023, formatted in Inline Extensible Business Reporting Language ("XBRL"): (i) the Condensed Consolidated Statements of Comprehensive Income, (ii) the Condensed Consolidated Balance Sheets, (iii) the Condensed Consolidated Statements of Shareholders’ Equity, (iv) the Condensed Consolidated Statements of Cash Flows, and (v) Notes to Condensed Consolidated Financial Statements.
101.INS						Inline XBRL Instance Document (the instance document does not appear in the interactive data file because its XBRL tags are embedded within the inline XBRL document).
101.SCH						Inline XBRL Taxonomy Extension Schema Document.
101.CAL						Inline XBRL Taxonomy Extension Calculation Linkbase Document.
101.LAB						Inline XBRL Taxonomy Extension Label Linkbase Document.
101.PRE						Inline XBRL Taxonomy Extension Presentation Linkbase Document.
101.DEF						Inline XBRL Taxonomy Extension Definition Linkbase Document.
104						The cover page from the Company’s Quarterly Report on Form 10-Q for the fiscal ~~second~~third quarter ended ~~April~~July 1, 2023, formatted in Inline XBRL and contained in Exhibit 101.

3234

Table of Contents

SIGNATURES

Pursuant to the requirements of Section 13 or 15(d) of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

Plexus Corp.

Registrant

Date:

~~April 26,~~August 4, 2023

/s/ Todd P. Kelsey

Todd P. Kelsey

Chief Executive Officer

Date:

~~April 26,~~August 4, 2023

/s/ Patrick J. Jermain

Patrick J. Jermain

Executive Vice President and Chief Financial Officer

3335


	Fixed Asset and Operating ROU Asset Impairment		Employee Termination and Severance Costs		Total
Accrual balance, as of October 2, 2021	$	—	$	71	$	71
Restructuring and impairment costs	255		1,766		2,021
Amounts utilized	(255)		(75)		(330)
Accrual balance, as of January 1, 2022	$	—	$	1,762	$	1,762
Restructuring and impairment costs	—		—		—
Amounts utilized	—		(100)		(100)
Accrual balance, as of April 2, 2022	$	—	$	1,662	$	1,662